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Abbreviations 
APC antigen presenting cell 
ACC antigen capturing cells 
AFC antibody forming cells 
BCR B cell receptor 
BrdU bromodeoxyuridthe 
BSA bovine serum albumin 
CDR3 complementarity determining region 3 
DC dendritic cell 
DNP dinitrophenyl 
ELISA enzyme-linked immunosorbent assay 
FACS fluorescence-activated cell sorting 
FCS foetal calf serum 
FDC follicular dendritic cells 
FITC fluorescein isothiocyanate 
FO follicular 
GC germinal centre 
IC immune complex 
ICOS inducible costimulator 
i.p. intraperitoneally 
i.v. intravenously 
KLH keyhole limpet haemocyanin 
LPS lipopolysacharide 
MHC major histocompatibility complex 
mRNA messenger ribonucleic acid 
MZ marginal zone 
NP 4-hydroxy-3-nitrophenyl acetyl 
OD optical density 
Ova ovalbumin 
Ox oxazolone 
PALS periarteriolar lymphoid sheath 
PBS phosphate buffered saline 
FE phycoerythrin 
phOx phenyl oxazolone 
PNA peanut agglutinin 
QM quasi-monoclonal 
RAG recombination activating gene 
RT-PCR reverse transcription polymerase chain reaction 
SRBC sheep red blood cells 
TCR T cell receptor 
TD thymus dependent 
TI thymus independent 
TNP trinitrophenyl 
XHIM X-linked hyperlgM 
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Abstract 
The cellular basis of immunological memory within the B cell compartment 
remains poorly defined. Although classically B cell memory has been attributed 
to an IgM-IgD- subset of resting B cells, more recent studies show that B cells 
bearing all the hallmarks of memory exist within 1gM and IgD bearing 
compartments. In addition, a novel memory B cell, that lacks typical B cell 
lineage markers, has been described. First, this study provides strong evidence 
that the B cell lineage negative memory cell described by others is in fact an 
unusual myeloid lineage cell. By absorbing serum IgO, in an FcyRl dependent 
manner, these cells appear to be antigen-specific. The possibility that these cells 
may have a role in regulating T helper cell and B cell responses has been 
investigated. Second, this study looks into the requirement of CD40 signals in the 
generation of non-classical 1gM memory. 
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Chapter 1: Introduction 
1.1 	Historical background 
The ability of the immune system to respond more efficiently and effectively 
to an antigen on second encounter is termed immunological memory. 
Centuries ago, well before the infectious nature of disease was understood, it 
was noted that an individual who survives a plague first time around is often 
resistant to subsequent outbreaks. The first attempt to manipulate this 
immunity is thought to date from the early 18th century. Deliberate 
inoculation with material from the pustules of mild cases of smallpox in an 
attempt to protect from a more severe and fatal form of the disease, a practice 
known as variolation, was widespread across Asia, Africa, the middle East 
and rural western Europe [1]. Subsequently the first vaccine - deliberate 
infection with the innocuous cow pox virus to provide life long immunity to 
the related small pox - was developed by Edward Jenner, following his 
observation that milkmaids rarely succumbed to small pox. However it was 
not until the late 19th century that the human and economic benefits of 
manipulating immunological memory were realised by prominent 
established scientists, namely Pasteur and Koch, leading to the founding of 
the science of immunology. 
Today we know the basis of immunological memory is an increase in the 
frequency of antigen-specific T and B cells, which is long lasting. This was 
originally proposed by Burnet in his Clonal Selection Theory of Acquired 
Immunity, to account for memory in antibody responses [2]. The central 
tenets of this theory: that each lymphocyte produces only a single antibody 
specificity and that clones of lymphocytes are selected and expanded by 
antigen through contact with antibody on the cell surface, have since been 
proved correct for both B cells and T cells [3]. In addition it is also now clear 
that memory is associated with enhancement of lymphocyte sensitivity to 
antigen on a per cell basis. This is due to increased affinity of the antigen 
responsive cells and/or adaptations in cellular function. 
1.2 Evolution of immunological memory 
Innate defence systems, in which broad classes of pathogens are recognised 
by invariant germline-encoded receptors, are ancient in evolutionary terms. 
Some of the key molecular signalling pathways involved in the recognition 
of pathogens and triggering of immune mechanisms are conserved between 
insects, plants and mammals [4]. Immunological memory is the hallmark of 
an adaptive immune system and it evolved relatively recently, being found 
only in the jawed fish and their descendents. The relatively sudden 
emergence of the ability to recognise and remember practically any 
compound, with a high degree of specificity, is attributed to the introduction 
of two completely novel enzymes, the recombination activation genes (RAG-
1 and 2). Together RAG-1 and RAG-2 mediate the randomised recombination 
of gene segments that form the T cell and B cell antigen receptors (TCR and 
BCR)[5]. The introduction of RAG genes into the vertebrate genome is 
estimated to have occurred 450 million years ago [6] and the discovery that 
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these proteins have transposase activity in vitro [7] gave credence to the 
theory that originally these constituted a transposable element or jumping 
gene [8]. The recombination of variable (V), junctional (J) and diversity (D) 
gene segments to form the variable antigen binding regions of antibodies and 
TCRs, was demonstrated in classic experiments by Tonegawa [9]. The actual 
size of the primary BCR repertoire generated by somatic recombination 
cannot be measured, however, now the number of functional VH and V K 
genes are known and very rough estimates of the combinatorial diversity can 
be made. Taking into consideration additional junctional diversity, these 
place primary human antibody diversity in the order of 10 different 
specificities. Thus Tonegawa's experiments provided the solution to the 
long-standing question of how the limitless specificity of the immune system 
could be encoded by limited genetic material. 
The selective advantages of adaptive immunity are considerable for animals 
with longer generation intervals and smaller numbers of offspring. Human 
conditions in which adaptive immunity is severely compromised, such as 
acquired immunodeficiency syndrome (AIDS) and X-linked Hyper-IgM 
(XHIM) quickly prove fatal without clinical intervention - indicating that 
acquired immunity is absolutely critical for individual survival. As surviving 
an infection once means you will likely survive it again, it has been argued 
that the major selective advantage conferred by B cell memory is not 
individual survival but in the ability to transfer immunity to vulnerable 
11 
neonates in the form of maternal antibodies [10]. However, it seems that 
individuals continually succumbing to common pathogens would be 
substantially less fit than their counterparts with acquired immunity. 
In acute infections both T and B cell responses are usually required to clear 
primary infection, whereas preformed neutralising antibodies are in many 
cases sufficient to confer protective immunity against secondary infection. As 
a result, most clinically successful vaccines to date elicit long-lived antibody 
responses [11]. In the case of chronic non-cytopathic viral infections or in 
diseases where the infectious agent is never completely cleared, but remains 
latent within tissues (for example tuberculosis and herpes virus infections), 
CD4 and CD8 T cell memory is thought to be critical for preventing re-
emergence [12], [13] 
The mechanisms leading to the formation, persistence and propagation of the 
memory cell pool have not been clearly defined in the T or B cell system. This 
study focuses on the mainly on memory in the B cell system, but it also 
considers how B cells, via secreted antibody, may regulate aspects of T cell 
memory and I would like to introduce both these topics. 
1.3 B cell development in the bone marrow 
Mature peripheral virgin B cells represent the starting repertoire of 
specificities from which B cell memory must develop. In textbooks, the 
development of naïve B cells and the subsequent development of memory 
and effector B cells are dealt with as two separate processes that are distinct, 
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not only temporally and anatomically, but also in that the former is antigen-
independent whereas the latter is antigen-driven. However, the picture that 
seems to be emerging from more recent work is that B cells are regulated 
continuously by antigen from an early stage in their development. Therefore, 
the path from B-cell precursor to memory cell or terminally differentiated 
plasma cell should perhaps be regarded as a continuum. 
Virgin B cells are generated firstly in the foetal liver, then in the bone 
marrow, and their production continues throughout adult life [14]. The 
diversity of the primary B cell repertoire is generated in the 
microenvironment of the bone marrow, by the processes of Ig light chain V-J 
and then heavy chain V- D-J gene segment recombination. Development 
progresses from a putative common lymphoid progenitor, through to pro B, 
then pre-B, and then immature B cell stages, which were originally 
characterised by Hardy [15] (Figure 1). 
The molecular basis of the sequential rearrangement of Ig gene segments and 
the processes of expansion and selection have now been revealed in great 
detail; the main check points of B cell development are illustrated in Figure 1. 
Successful heavy (H)chain rearrangements are tested at the early pre B cell 
stage by pairing with the surrogate light chain. Expression of this pre-BCR at 
the cell surface signals an end to H chain rearrangements [16, 17] [18], and 
leads to a phase of clonal expansion followed by rearrangement of the light 
(L) chain [19]. It is not yet clear whether the pre-BCR requires a ligand to 
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mediate these effects; that proliferation and differentiation progress in vitro, 
in the absence any stromal cells would argue against this [20]. 
Late pre B cells with successful heavy 4 chain and ?. or K light chain pairings 
that bind to self antigens in the bone marrow have three fates, they are either: 
eliminated by apoptosis [211; become anergic [22]; or are given a second 
chance and return for further light chain rearrangement, a process known as 
receptor editing [23], [24]. This selection event signals the start of the antigen-
dependent phase of B cell development. Pre B cells passing this check point 
progress to the immature compartment. 
The processes discussed ensure that each cell in the immature B cell 
compartment expresses a single BCR specificity, a phenomenon known as 
allelic exclusion [25]. This compartment is also purged of potentially harmful 
self-reactive specificities. Immature B cells reaching this stage then up-
regulate 1gM and are exported to the periphery, these are then classified as 
transitional B cells [26]. 
1.4 	Selection in to the long-lived mature B cell pool 
Transitional B cells are short lived and can be distinguished from mature B 
cells as they express only low levels of IgD and CD21 [27]. They are found 
only in the blood and the spleen, where they are excluded from the B cell 
follicles. Only 10% of B cells leaving the bone marrow reach the spleen and 
only 30% of these are incorporated into the long-lived, recirculating mature B 
cell pool [28]. 
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The basis of this selection is not well understood but it is thought to involve 
signals from the BCR as the conditional ablation of 1gM expression blocks 
development from transitional to mature B cell [29] and targeted mutations 
in components of BCR signalling such as Iga, CD45 and Btk also inhibit this 
progression [30]; [31]; [32] This is a flexible checkpoint as depletion of the 
mature B cell pools allows greater numbers of transitional B cells entry to the 
mature compartment until equilibrium is re-established [33]. 
The entry of B cells into the mature peripheral pool could be a stochastic 
event or it could be the result of negative or positive selection on the basis of 
BCR specificity. The strongest evidence that this is a selective process 
determined by BCR specificity comes from a study by Shlomchik and 
Janeway, who compared the V K sequences of peripheral, transitional and 
mature naïve B cells from transgenic mice in which the H chain is fixed [34]. 
While the transitional repertoire was found to be diverse, there was over-
representation of a minority of V K in a pattern consistent with positive 
selection. However the ligands, be they self or environmental antigens, have 
not yet been defined. In a recent review Janeway describes experiments from 
his group that show secreted Ig itself mediates positive selection of B cells 
[35], however, this data has not been published yet. 
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1.5 Mature B cell compartment 
Mature B cells in rodents and humans can be divided into three distinct sub-
groups on the basis of surface phenotype, anatomical location and function. 
The majority of mature B cells recirculate through the B cell follicles of 
secondary lymphoid organs, initially demonstrated by Nieuwenhuis and 
Ford [36]. These are typically IgDght  IgMdull cells and are termed follicular 
(FO) B cells. FO B cells are relatively long-lived (3-6 weeks) [37] [38] and their 
continued survival is known to require intermittent signals from the BCR as 
conditional genetic ablation of surface Ig reduces the lifespan of mature B 
cells [29] However, the nature of the ligand(s) that signal B cell survival has 
not been established; it may be that expression of the BCR at the cell surface 
provides sufficient endogenous signal (as is thought to be the case for the 
pre-BCR signalling during development). Alternatively, the survival of naïve 
B cells may require intermittent "tonic" stimulation from peripheral ligands, 
in the same way that peripheral survival of naïve CD4 and CD8 T cells is 
thought to require low level stimulation through recognition of MHC 
molecules [39] [40] [41] [42]. 
The marginal zone of the spleen in humans and rodents is enriched in 
IgMbright, IgDdul1, CD21high B cells, which are termed marginal zone (MZ) B 
cells. Smaller numbers of B cells with a similar phenotype can be found in 
defined areas of other lymphoid organs that correspond to the splenic 
marginal zone. MZ B cells do not recirculate [43] and have a more activated 
phenotype than FO B cells, in that they are larger and express higher levels of 
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the costimulatory molecules CD80 and CD86 [44]. MZ B cells have more 
rapid responses to antigen than FO B cells; they proliferate and differentiate 
into plasma cells and acquire antigen-presenting capacity much quicker and 
with greater efficiency, particularly in response to low doses of TI-1 antigens 
[45]. It was initially proposed that the main function of MZ B cell was to form 
rapid, early antibody responses to polysaccharide antigens on encapsulated 
bacteria, however this was difficult to prove. More recently Pyk-2, a 
signalling molecule downstream of the chemokine receptors, was shown to 
be essential for the development of MZ B cells [46]. Thus, the Pyk-2 deficient 
mice provided the first MZ B cell knock-out. These mice are defective in 
responses to TI-TI antigens (supporting earlier assumptions mentioned 
above), but they also have defective IgG2a production, revealing a role for 
MZ B cells in TD responses. 
A third subset of mature B cells, the Bi B cells, are found in much smaller 
numbers in the spleen, but predominate in the peritoneal and pleural cavities 
[47]. These are also IgM cells with an activated phenotype, and are unusual 
in that they are Mac-1 and a proportion of them are CD5[47]. In contrast to 
MZ B cells, which develop after birth, Bi cells develop early in ontogeny and 
can self-replenish. An important function of Bi B cells seems to the secretion 
of natural antibody, which provides an important layer of early non-adaptive 
immunity. 
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The relationship between MZ, Bi, FO and transitional B cells is not clear. In 
the past FO and MZ B cells were believed to originate from distinct 
recirculating precursors [48]. However more recent studies support a model 
in which transitional B cells are recruited into FO, MZ or Bi B cell 
compartments on the basis of BCR signals [49]. B cells from BCR transgenic 
or knock-in mice have been shown to segregate into distinct mature 
compartments depending on the particular H-L chain combination and the 
level of BCR surface density, [50]; [51]; [52]. 
The pre-immune repertoires of Bi and MZ B cells appear to be similar, and 
distinct from that of FO B cells, in that they are enriched for multi-reactive 
specificities that can recognise common pathogenic epitopes as well as some 
ubiquitous self-antigens [49]. In addition it has been suggested that there is 
some level of redundancy between Bi and MZ B cell populations [53]. The 
MZ B cell populations develop in the absence of T cell signals and in germ-
free mice [33], leading to the proposal that these are virgin cells, positively 
selected for multi-reactivity by self antigen [49]. Bi cells, however, may be 
selected by (1) foreign antigen, as transgenic anti-RBC B cells are not selected 
in to the Bi compartment in germ-free mice [54] and (2) by self antigen as 
recent anti-thy-1 Bi cells are not found it the absence of the self antigen [55]. 
Because of their innate multi-reactivity MZ and Bi cells termed natural 
immune memory cells by Martin and Kearney [49], and are proposed to link 
innate and adaptive immunity. However the possibility that these cells enter 
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the conventional memory B cell differentiation pathway, or that they may 
represent non-switched but bona fide antigen-experienced memory cell 
compartments, has not been fully investigated. 
1.6 T-dependent and T-independent antigens 
The type of B cell response generated in vivo is influenced by the nature of 
the antigen. A useful, broad classification of antigens is based on the 
antibody responses of the Nude mouse, a congenitally athymic strain which 
lacks T cells. Antigens that elicit antibody responses in normal mice, but not 
in Nude mice, are termed thymus-dependent (TD) antigens. Those antigens 
that do elicit antibody responses in Nude mice are termed thymus-
independent (TI) antigens. Antibodies can recognise protein, lipid, 
carbohydrate and nucleic acid epitopes; they can also be raised against small 
organic molecules, termed haptens, but only when these are covalently 
conjugated to a TD or TI carrier-antigen. 
TD antigens are protein-based molecules, which B cells can process and 
present, as peptides bound by MHC class II molecules, to specific CD4 T 
cells. Sheep red blood cells (SRBC) are a classic model TD antigen. Cognate 
interaction between B and T cells allows specific delivery of T cell help 
signals (both soluble and membrane bound factors) that, in conjunction with 
BCR signals, lead to B cell activation (Figure 2). The requirement for antigen-
specific 'help' during TD antibody responses was first demonstrated by 
Mitchison [56]. Mice were immunised with a hapten-carrier conjugate and it 
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was shown in vitro, that splenocytes produce an anti-hapten antibody 
response to the original hapten-carrier combination but not to the same 
hapten conjugated to a different carrier. The helper cells were subsequently 
proven to be T cells and the T-B interaction was shown to be MHC restricted 
[57]. 
TI antigens are carbohydrate and lipid-based, and therefore, do not support 
cognate collaboration between T and B cell. They are divided into 2 subsets 
- TI-1 and TI-2. TI-1 antigens possess intrinsic mitogenic qualities and act as 
polyclonal B cell activators [58]. These mitogenic signals tend to be broadly 
conserved structural constituents of microbes, such as lipopolysaccharide 
(LPS), which are recognised by the innate antigen receptors of B cells and 
other accessory cells and most likely activate NFKB via members of the Toll-
like receptor (TLR) family [59]. A commonly used model TI-1 antigen is 
hapten conjugated LPS, e.g. TNP-LPS. TI-2 antigens are repeating polymers 
which cross-link large numbers of BCRs and, as a result, are thought to 
induce B cell activation independent of T cell help [60]. Model TI-2 antigens 
include haptenated carbohydrate polymers such as nitrophenyl-ficoll (NP-
ficoll), and arrays of anti-Ig antibodies displayed on a dextran backbone. 
In the mouse, model TD antigens can elicit robust antibody responses of all 
isotypes, whereas model TI antigens induce only 1gM and IgG3 responses. 
However infection with certain viruses can elicit protective IgG2a, IgG2b or 
IgA responses in mice that lack conventional c43 T cells [61]. It appears, 
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therefore, that the rules for model antigens do not always apply to real, 
replicating antigens that interface with the immune system in a more 
complex way. 
Early studies showed that recall antibody responses develop only following 
immunisation with TD antigens, and are predominantly of the IgG isotype, 
[62]. The requirement of cognate T-B cell interaction for the development of 
recall responses was first demonstrated by Pillai eta! [63]. This has become 
the accepted view, although in the past, several studies demonstrated IgG 
and 1gM recall responses to various TI-1 and TI-2 antigens [64]; [65];[66] 
However these studies were not in agreement with regard to the level and 
nature of this memory and so T-independent memory was not generally 
accepted in principle. The following account of memory B cell generation 
deals largely with the classical T-dependent model. 
1.7 	Early T cell-B cell interaction 
Cognate interaction between T and B cells is not sufficient to initiate an 
antibody response in vivo. A third party, antigen presenting cell, which has 
been identified as the dendritic cell (DC) is required to first prime naïve T 
cells before they can activate B cells [67]. Detailed in situ histological studies 
of antigen-specific B cells, initiated by MacLennan's and Kelsoe's groups, 
have revealed the early cellular events involved in T-dependent antibody 
responses. MacLennan's group identified hapten-specific B cells on the basis 
of their antigen-binding capacity. Kelsoe's group detected NP-specific B cells 
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in B6 mice on the basis of their predominant usage of the relatively rare ?1 
light chain. The histological studies from both these groups showed that B 
cell initially encounter antigen and interact with specific T cells in the T-rich 
zones of secondary lymphoid organs, within 2 days of immunisation [68], 
[69] (Figure 2). One of the difficulties of these studies is that naïve antigen-
specific B cells are extremely rare, so the very early events cannot be 
followed. Jenkins' group have pioneered the technique of adoptively 
transferring small but detectable numbers of naive transgenic T and B cells 
into normal hosts then immunising [70]. In this way, the very earliest events 
can be clearly visualized. This approach has pinpointed the initial T-B cell 
interaction more precisely to the borders of primary B cell follicles [71]. 
It has been shown that dendritic cells in the periphery, such as the Langerhan 
cells of the skin, endocytose antigen and then migrate via the afferent 
lymphatics to the I zones of lymph nodes where they present processed 
antigen to naïve T cells [67]. However, it is not clear where naive B cells first 
encounter antigen. Like T cells, follicular B cells recirculate through primary 
lymphoid tissues. They gain access to lymphoid tissues from the circulation, 
passing first through the T-cell area before entering the B-cell follicles. If they 
do not encounter specific antigen on this journey they will exit via the 
efferent lymphatics and re-enter the circulation via the thoracic duct. A 
network of non-endocytic stromal cells, called follicular dendritic cells (FDC), 
exists within the follicle that are specialised for the capture of native antigen 
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to their surface [72]. However, given their anatomical location, it seems 
unlikely that these are involved in the initial activation of B cells. 
The splenic marginal zone and the sub-capsular sinus of lymph nodes are 
structures that are rich in macrophages and seem to be specialised to filter 
and capture antigen from the blood and afferent lymph respectively. Tew 
initially proposed the existence of a non-phagocytic antigen-transporting cell 
that would bring native antigen from these sites into the T zones [73]. Since 
then, Kosco-Vilbois and colleagues have identified a sub-population of 
dendritic cells in mouse lymph nodes that bind a soluble mannose receptor 
and in this way can capture antigen rapidly after immunisation [74]. These 
cells start accumulating at the follicular border, intermingled with T and B 
cells, within 24 hours of immunisation. The authors propose that these 
dendritic cells migrate into lymph nodes from peripheral sites, carrying 
intact antigen that has been bound by the mannose receptor, and are 
subsequently involved in activating T and B cells at the follicular border. 
Activation of B cells by antigen and by cognate interaction with antigen-
specific T cells (primed by DCs) has two possible outcomes for the B cell. 
First, some B cells are induced to divide locally and form extra-follicular foci 
of proliferation and antibody production. B cell proliferation in extra-
follicular sites continues for up to a week after immunisation and the low-
affinity antibody-forming cells (AFC), which first appear at day 3 and are 
largely gone by day 10, are short lived (2-3 days) [75, 76]. 
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Alternatively, some activated B cells migrate into the primary B cell follicles 
and found germinal centres (GC), where further maturation and 
differentiation occurs. It is not clear how the initial cell fate decision between 
early plasma blast and GC B cell differentiation paths is made. Comparisons 
of V gene sequences from individual B cells of GCs and nearby extra follicular 
foci showed that B cells from the same clone were found in both [77] but it is 
not clear if extra-follicular proliferation is a general prerequisite for GC 
founders. 
The existence of distinct Ig isotypes allows for specialisation of the late 
primary and memory B cell responses. Differences in the Fc portion of 
secreted Ig provide a diversity of effector functions. There are also marked 
isotype differences in the cytoplasmic domains of membrane 1g, however the 
functional significance of this is not clear. Experiments with BCR transgenic 
mice that express a chimaeric form membrane p., which has the yl 
transmembrane/cytoplasmic domin, have revealed clear signalling 
differences in the context of development [78]. It is likely that differences in 
the signalling potential of Ig isotypes also accounts for differences in the 
responses of naïve and memory B cells [79]. Sterile RNA transcripts are 
produced in B cells prior to isotype switch recombination. These switch 
transcripts are very short lived and so can be used as a marker of B cells that 
are actively class-switching. Toellner et al [76] quantified switch transcripts in 
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Figure 2 	Classic T-dependent generation of B cell memory 
3• 








Mob- 01", 	 C BOBI 
• T cell 
Cognate interaction occurs between antigen specific T and B cells at the 
follicular border (1). B cells may then form foci of extra-follicular proliferation 
and antibody production (2) or migrate into the follicle, followed by antigen-
specific T cells, and form germinal centres (3). B cells that survive germinal 
centre selection emerge as either long-lived plasma cells or resting memory 
B cells (4). 
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the spleens of immunised mice and found that the bulk of class switching 
occurred before the formation of GCs. This suggests that the decision to class-
switch to down-stream isotypes is made during the initial T-B interaction in 
the T zones, and not during later T-B interaction in the GC, [80]. Thus the 
initial T-B collaboration during the primary response is a critical decision 
point in the development of appropriate memory response. 
1.8 The germinal centre 
Germinal centres (CC) are distinctive structures of rapidly dividing B cells, 
which develop in the primary B cell follicles within the first week of 
immunisation with a TD antigen. It is now clear, as had long been suspected, 
that GCs are the site of memory B cell production. One of the earliest 
demonstrations of this was when GC B cell populations isolated at early 
stages of the reaction were shown to transfer memory responses [81]. The GC 
reaction has since been proven to be pivotal in the maturation of primary 
antibody responses and the development of B cell memory through studies of 
human and mouse GCs [69], [82], [83], [84]. In these studies GC and non GC B 
cells were either microdissected from histological sections or sorted on the 
basis of surface markers; the V genes of these cells were then sequenced and 
compared, revealing that mutated memory cells originate from the CC. 
In response to model protein antigens, GCs tend to peak in numbers at 
around 14 days and persist for around 30 days [85] although there are reports 
of CC phenotype B cells persisting for up to 80 days [86], and virally-induced 
GCs can last significantly longer [87]. In addition to cycling B cells, GCs 
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contain a population of CD4 T cells that are antigen-specific [88]; a 
subpopulation of CD4 dendritic cells [89]; and a supporting stromal-network 
of follicular dendritic cells (FDC.). In addition, there are a substantial number 
of macrophages that deal with the large amount of apoptotic cell death that 
occurs in counterpoint to the B cell proliferation in the GC. Apoptotic bodies 
are visible within these macrophages, making them morphologically 
distinctive and they are termed tingible body macrophages. 
1.9 Molecular interactions regulating germinal centre development 
As mentioned, signals from helper T cells are required for GC initiation but 
later signals from GC T cells are also required for GC maintenance. 
MacLennan's group found that NP-specific knock-in B cells formed GC 
structures in response to immunisation with the TI-2 antigen NP-ficoll, 
showing that the initiating T-dependent signal can be over-ridden [90]. 
However these GC rapidly disintegrated 5 days alter immunisation, 
indicating that the maintenance of GCs and the onset of somatic 
hypermutation are absolutely dependent on T cell signals. 
In particular, CD40 on B cells and its ligand, CD154, which is induced on T 
cells following activation, have been shown to be critical for the development 
of germinal centres and B cell memory. Mice engineered to be defective in 
either of these molecules to do not form GCs and have severely diminished 
primary and secondary IgG responses to TD antigens [91], [92]. Treatment of 
pre-immunised mice with CD40-Ig leads to the rapid collapse of established 
GCs [93], indicating that CD40 signals are required for both the initiation and 
maintenance of germinal centres. 
In addition to CD154, the costimulatory molecule ICOS is expressed by 
activated T cells is involved in GC development. Initial papers showed that 
ICOS was predominantly expressed by GC T cells [94] and its ligand, B7RP-1, 
is expressed on B cells but not DC (unlike CD40) [95]. This suggested the 
ICOS-B7RP-1 pair had a specialist role in regulating TD antibody responses. 
Consistent with this, ICOS knock-out mice have few GC and decreased 
antibody production [96-98]. And conversely B7RP-1 over expressing 
transgenic mice have enlarged lymphoid tissues which are full of GCs and 
plasma cells [99]. 
A key function of these costimulatory interactions may be to regulate GC 
formation at the level of cell migration. Mature B cells, and a subset of 
activated T cell express the chemokine receptor CXCR5 (formerly BLR1), 
which recognises BLC. FDC are believed to secrete BLC and this is proposed 
to act in concert with other signals to attract activated B cells and T cells from 
the T zone into the primary follicle [100]. 
1.10 Affinity maturation of B cells in the germinal centre 
The average affinity of serum antibody for antigen normally increases with 
time. This molecular evolution is known as affinity maturation and is the 
result of two processes that occur in the specialised microenvironment of the 
GC. First, Ig V genes of specific B cells are diversified by the introduction of 
point mutations, a phenomenon known as somatic hypermutation. 
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Subsequently, the high-affinity variants that arise are preferentially selected 
for survival and expansion on the basis of antigen binding. The molecular 
basis of this Darwinian evolutionary process has been an area of intense 
study. The precise mutator mechanism remains elusive, however the 
prevailing model invokes a two-stage mutation process. Firstly, nicks or 
double strand breaks are introduced into V regions that are being actively 
transcribed, these are then repaired by an error prone DNA polymerase 
which introduces the mutations [101]. An RNA editing enzyme, activation-
induced cytidine deaminase (AID), has been shown to be critical for both 
somatic hypermutation and class switch recombination [102], which has led to 
the proposal that these two processes occur by a common mechanism. 
The correlation between GC formation and the appearance of mutated B cells 
led to the proposal that GCs are the sites of affinity maturation [33]. Berek [83] 
and Jacob [69] showed directly that somatic hypermutation occurred in GCs. 
Jacob and co-workers microdissected single B cells from GCs and 
extrafollicular foci then sequenced their V genes. They found V-gene 
mutations in only the GC B cells. In this study, the genealogy of B cells from a 
single GC could be constructed on the basis of accumulated point mutations. 
This analysis predicted that only 1-3 B cells seeded GCs, and that somatic 
mutation in GCs proceeds through multiple rounds of mutation and 
proliferation. Berek's group isolated GC B cells on the basis of their affinity 
for peanut agglutinin (PNA) - only GC B cells upregulate the sialic acid 
modification that this lectin recognises. V-region sequencing showed that 
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mutations in response to 2-phenyl-oxazolone (phOx) were detectable in PNA 
GC B cells from day 12, whereas mutations did not appear in the non-GC 
(PNA -) B cells until alter GC demise, 4 weeks alter immunisation. The 
implication of this is that B cells undergo mutation during the germinal centre 
reaction and only when B cells exit this reaction do somatically mutated 
(memory) B cells appear in the periphery. 
Activated B and T cells that have migrated into the primary follicle collect 
within the FDC network. Antigen-antibody-complement complexes, which 
are retained on the FDC surface, together with signals from T cells, drive and 
sustain the GC reaction. The immigrant B cells are induced to proliferate and 
at an early stage the GC becomes polarised into the light zone and the dark 
zone. The dark zone contains rapidly dividing B cells, called centroblasts, that 
have down regulated their surface immunoglobulin. The light zone contains 
resting B cells, called centrocytes, which are surface Ig. Cell labelling studies 
have shown that centroblasts are dividing extremely rapidly, once every 6-7 
hours [68]. The dividing centroblasts accumulate mutations then exit cell cycle 
and move to the light zone where they re-express surface 1g. These cells have 
upregualted pro-apoptotic molecules and downregulated anti-apoptotic 
molecules and so will undergo apoptotic cell death unless they are positively 
selected. Selection is thought to require both signals from antigen -specific 
helper T cells (CD40 signals) and the antigen, bound to FDCs. Thus, 
centrocytes that receive little or no BCR signal, or those that receive a BCR 
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signal but no CD40 signal will die. In this way, low affinity or potentially 
harmful autoreactive B cells that may arise [103] are lost. 
Positively selected GC B cells may re-enter the dark zone for a further round 
on mutation or they may exit the GC reaction and differentiate to either 
memory cell or plasma cell. It is not clear if this cell fate decision is stochastic 
or whether selection occurs on the basis of BCR affinity. Temporally, there 
seem to be differences in the appearance of these two compartments. In 
immune responses to the hapten NP a functional memory cell population can 
be detected from day 14 of the germinal centre reaction [86] whereas the 
plasma cell population emerges (largely in the bone marrow) earlier, at 
around 7-10 days [75]. In one study Smith and co-workers found that 
although the plasma cell population had undergone less somatic mutation, 
they had a greater proportion of high affinity BCRs [104]. This is consistent 
with a model in which the long-lived plasma cell pool is stringently selected 
on the basis of affinity early in the GC reaction, whereas the bulk of memory 
B cells are formed later - coinciding with the decline of the GC reaction - 
and as a result are less highly selected on the basis of affinity. However, a 
recent study, also of the NP response, reports that the memory compartment 
consists largely of B cells that have a low level of mutations (compared to GC 
B cells) [105]. This suggests that memory B cells are actually selected from 
early GC precursors. Fas is highly expressed on GC B cells and the same 
study detected aberrant selection of memory cells in lpr/lpr Fas deficient mice. 
In the absence of Fas it appears that late GC B cells are selected into the 
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memory pool resulting in the accumulation of heavily mutated memory B 
cells. This suggests that Fas is involved honing the repertoire of memory B 
cells 
1.11 Memory cells and long-lived effector cells 
As mentioned, protective immunity by B cells is mediated by pre-formed 
antibody. In the case of certain viral infections protective antibody can last a 
lifetime in the absence of re-exposure to the virus. One famous example of 
this is Faroe islanders who were still immune to measles infection after a 70 
year period when the virus was absent from the island [106]. It was originally 
proposed that very long-lived, resting memory B cells were responsible for 
the persistence of B cell memory in the absence of antigen [107]. As, initial 
estimates of plasma cell lifespan were in the order of weeks. This led to the 
proposal that intermittent stimulation with residual or cross-reactive antigen 
is required to replenish the plasma cell population. However, recent work has 
revealed that plasma cells can clearly be very long-lived. In the mouse bone 
marrow they have been shown to persist with out dividing for 120 days [108], 
[109]. These long-lived plasma cells down-regulate their BCRs and survive 
and secrete antibody independent of antigen [110]. In mice, these cells can 
provide long-term (although not quite life-long) protective immunity in the 
absence of memory B cell precursors or antigen. However as these cells are 
unresponsive to antigen they are not by definition memory cells, although 
they have been described as such [111]. 
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The existence of long-lived effector cells that resemble, but are not actual, 
memory cells may not be limited to the B cell system. Recently two subsets of 
memory T cell have been described: CCR7 central memory cells (TCM) and 
CCR7- effector memory cells (TEM) [112, 113]. Central memory T cells are 
resting, recirculate through lymphoid tissue, do not express effector 
molecules and respond vigorously to antigen. Whereas effector memory T 
cells patrol non-lymphoid tissue, express effector molecules and seem to have 
limited proliferative responses response to antigen [114], [115]. 
1.12 A novel memory B cell 
Recently, there have been reports of a novel memory B cell compartment 
[116], [117]. This cell was detected on the basis of hapten-binding and surface 
IgG expression and is believed to be a product of the germinal centre reaction. 
This population is found in the spleen and bone marrow and quickly emerges 
as the dominant memory cell population in these systems. As this cell does 
not secrete Ig it is clearly not a plasma cell and it is distinct from conventional 
memory B cells as it lacks the B cell lineage markers B220 andCD19. These 
markers are critical components of BCR signalling therefore this cell must 
have dramatically different functionality from conventional memory cells. It 
is not clear where this novel, affinity matured, memory cell compartment fits 
into the current view of B cell differentiation, or how it responds to antigen in 
the absence of co-receptors. Nonetheless, this compartment was shown to 
transfer recall antibody responses on adoptive transfer. It has been suggested 
that this cell serves as a plasma cell precursor, however experiments by others 
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[108] have shown that the bone marrow plasma cell pool is long-lived and is 
not replenished after the immune response has subsided. 
1.13 Identifying memory B cells 
One problem in studying the induction of a memory B cell pool is the 
identification of these cells. Classically these have been assumed to be high 
affinity, class switched, resting B cells. The combination of IgG expression and 
binding of specific antigen has been used in past studies of memory B cells in 
mice [118]. However, germinal centre B cells and plasma cells would also 
meet this definition. Amongst B cells, plasma cells exclusively express the 
adhesion molecule syndecan-1 (CD138) and can be excluded on this basis. In 
the mouse CD38 is expressed by naïve B cell but is down regulated in the 
germinal centre. Tarlinton and co-workers showed that memory B cells re-
express CD38, and they have used this marker to study the kinetics of the 
establishment of the memory cell pool [86]. Interestingly this molecule can 
also be used as marker in humans where CD38 has the reciprocal expression 
pattern; low on naïve cells and upregulated on GC cells [119]. On human 
peripheral blood B cells CD27, a TNF receptor family member, is expressed 
exclusively by B cells bearing somatically diversified Ig V genes - a 
hallmark of memory, although not an absolute marker [120]. This discovery 
has revealed the full extent of cellular heterogeneity in the memory B cell 
pool. Together non-switched, 1gM and IgD positive B cells account for 60% of 
CD27 B cells in humans [120]. This confirmed earlier reports of IgD and 
IgM memory cells [121], [122]. While 50% of human peripheral blood B cells 
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are CD27 only around 2% of mouse peripheral B cells are CD27 (H. White 
personal communication). This low figure roughly correlates with the 
percentage of adult mouse B cells that somatically mutated, but it is not 
known if CD27 is a marker of memory on mouse B cells. A recent study 
detected substantial 1gM and IgD memory responses at the mRNA level in 
mice [123], implying that there is also a non-switched memory compartment 
in mice. Together these studies demonstrate that IgD or 1gM expression does 
not necessarily mark virgin B cells in mouse or man. This new perspective on 
the make-up of the B cell memory pool calls for a reassessment of the 
conditions leading to memory B-cell generation and survival. 
The origins and functions of non-switched memory B cells are not known. 
Recently it has been shown that a sub-population of IgMCD27 somatically 
mutated B cells exists in X-linked hyper-IgM (XHIM) humans, who lack 
functional CD154 - implying there is a memory B cell differentiation 
pathway that is independent of germinal centres and CD40-CD154 signals 
[124] 
1.14 Life span of Memory B cells and the role of antigen 
Initially, the longevity of B cell recall responses was attributed to the 
formation of a colony of long-lived resting cells [107], [125]. This view was 
challenged by adoptive transfer experiments, which showed that B cell 
memory was short lived in the absence of persistent antigen, [126]. This led to 
the proposal of a model in which B cell memory persists at the population 
level due to intermittent stimulation by antigen, which induces a slow rate of 
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division of memory B cells [106]. The proposed source of antigen was 
immune complexes, which were known to persist on the processes of FDC for 
years following immunisation [127], [128], [129]. This model was challenged 
by a study which examined the turnover of antigen-binding IgG memory B 
cells in intact mice and found them to be largely long-lived non-dividing cells, 
(although, even at 20 weeks post immunisation, 10% of memory B cells 
underwent division in an 18 day period), [118]. The classic view of memory B 
cells as long-lived cells is further supported by studies in TNFR1 -I- mice, 
which lack FDC networks. B cell memory to a viral antigen was long lived in 
these mice [130]. In addition, B cell memory was found to develop and persist 
normally in mice that lacked detectable antigen on FDCs (due to an genetic 
deficiency of the secretory form of 1gM) [131]. However, it is difficult be 
certain that antigen has been completely excluded from these experimental 
systems, particularly those involving replicating viral antigens. 
Recently, an elegant genetic solution this problem was applied by Rajewsky's 
group[132]. Mice were engineered that carried two distinct Ig H chain alleles 
and Gre recombinase under the control of an inducible promoter. When 
paired with a ? light chain, one of these H chains forms an NP specific 
immunoglobulin, the other a PE specific immunoglobulin. However, only the 
NP specific allele is in an orientation that can be expressed, the PE specific 
allele was inverted. Both alleles were flanked with loxP sites however these 
were orientated so that Cre-mediated recombination would mediate inversion 
of the PE-specific allele into the correct orientation and deletion of the NP 
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specific allele - in effect switching the specificity of the B cell. As a result, 
before induction of Cre, a detectable proportion of naive B cells expressed a 
BCR specific for the hapten nitrophenyl (NP). These mice could be immunised 
to generate NP specific memory B cells. However, induction of Cre results in 
a proportion of these B cells switching to a PE-specific BCR. As these mice 
had never been exposed to PE, and NP is unrelated to PE, the switched PE-
specific memory B cells could receive no signals from specific antigen. 
However these cells were shown to persist as well as those memory B cells 
that remained NP-specific, (and so could be stimulated by specific antigen). 
This study showed that it is possible for memory B cells to survive for at least 
12 weeks in the absence of stimulation from specific antigen, and without 
dividing. 
However, this study does not exclude a requirement for non-specific tonic 
BCR signals for the maintenance of memory B cells. In addition the size of the 
memory B cell pool is likely to be limited and, under normal circumstances, 
will be kept in check by homeostatic mechanisms. It is clear from this 
experiment that a population of memory B cells does not require antigen to 
persist in an essentially oligoclonal memory cell pool where there are few 
competing memory B cell clones. However, in the heterogenous memory pool 
of a normal animal, where there is competition for maintenance in this niche, 
persistent antigen on FDC may be critical for survival of a clone. In the case of 
endemic infections this would obviously come from repeated exposure. 
Environmental re-exposure aside, it is clear that infections that are apparently 
cleared often persist at a low level, contained by the immune system. For 
example Mycobacterium tuberculosis remains dormant within granulomas and 
its re-activation commonly occurs in the immunosuppressed, such as AIDS 
patients. Childhood viral infections such as measles and chicken pox also re-
immerge in the immunosupressed, in the absence of any external source of 
infection. In addition follicular dendritic cells provide a long-lived source of 
native antigen that can be source of stimulation for memory B cells. Further 
evidence for the role of antigen in maintaining memory and protective 
immunity comes from the observation that unlike their virulent counterparts, 
vaccines based on killed or proliferation attenuated viruses, require several 
doses to establish immunity and may require booster doses to maintain 
protection. 
It is not known which factors promote the survival of long lived memory B 
cells or plasma cells in the absence of antigen. Cognate interaction with T cells 
is known to be critical for the induction of memory B cells and in the 
production of recall antibody responses. However depletion of CD4 T cells 
with antibody was shown to have no detrimental effect on the maintenance of 
B cell memory responses [133]. It is not clear if all CD4 T cells were depleted 
in this study, however the more recent study [132] strongly suggests that 
memory B cells may not require cognate interaction with memory T cells to 
survive. 
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1. 15 Factors contributing to enhanced recall antibody responses 
Immunological memory, as we define it, is a property of a whole system, and 
not a function that is isolatable within a single-cell type. Secondary antibody 
responses to TD antigens as measured by antigen specific ELISA are 
predominantly IgG and are faster, bigger and of higher affinity than primary 
responses. This is due in part to the affinity maturation and clonal expansion 
of specific cells that occurs during the primary response. It has been proposed 
that resting memory cells have a lower activation threshold and can 
differentiate to effectors quicker than naïve cells. There is some evidence that 
this is true for memory T cells [134], [135], however, this has not yet been 
shown for memory B cells. But, the cytoplasmic tails of IgG sub types are 
much longer that IgD and 1gM and probably contribute to distinct signalling 
in naïve and IgG memory B cells [79]. 
Altered homing properties of memory B cells may also to contribute a more 
efficient secondary response, for example a significant proportion of memory 
B cells in the spleen reside in the marginal zone, where antigen is initially 
encountered [68]. Helper T cells are also critical for the formation of 
secondary B cell responses and increased numbers of antigen specific T cells 
are partly responsible for the speed of recall antibody responses [85]. In 
addition, the longevity of antibody responses means during the initiation of 
secondary responses pre-formed high affinity antibody will serve to enhance 
antigen presentation, although the precise way in which this contributes to 
the efficiency of secondary T and B cell responses is not known. 
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1. 16 Replenishment of the memory B cell pool 
On secondary challenge, memory B cells differentiate rapidly into plasma 
cells in the T zones and red pulp of the spleen [85], the pool of specific 
memory B cells must, therefore, be replenished. GCs also form during 
secondary responses [136], but it is not clear whether these are founded by 
memory cells. The processes of replenishment of the memory pool and 
replacement in the long-lived plasma cell population are poorly understood. 
It is not known to what extent memory B cells self-replenish or are generated 
afresh, in secondary GC reactions. The role of non-switched IgM, IgM IgD 
and IgD memory B cells subsets has yet to be determined and it is possible 
that they may have the capacity to replenish the memory pool. It is not known 
whether these cells are only programmed to differentiate to 1gM or IgD 
secreting cells, or whether they undergo further affinity maturation and 
isotype switching in secondary responses. However a recent report showed 
that human CD27IgMIgD memory B cells are able to isotype switch, 
whereas CD27 IgG and IgM B cells have limited capacity to switch to down 
stream isotypes [137]. 
1.17 Antibody can enhance or inhibit T and B cell responses 
It is clear that antibody, in the form of immune complexes (IC) can exert 
potent regulatory effects on B-cell and T-cell responses. Acting via 
complement receptors and inhibitory and activation Fc receptors, antibody 
can alter the way in which the antigen is seen and handled by the immune 
system. Classically, the role of antibody has been studied by immunising with 
immune complexes or by administering free immunoglobulin prior to 
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immunisation with SRBC. These approaches showed that specific antibodies 
can completely suppress B cell responses or enhance sensitivity to antigen 
more than one-hundredfold. This suggests antibody that is produced as an 
immune response develops may be involved in feedback regulation. Also, 
pre-existing IgG secreted by long-lived plasma cells in the bone marrow could 
influence secondary T and B cell responses However, the physiological role of 
antibody in regulating B and T cell responses is not known. 
Suppression of antibody responses by IgG has an important clinical 
application in preventing Rhesus-D-antigen negative pregnant mothers 
becoming immunised against foetal RhD red blood cells. This practise is 
highly effective in preventing haemolytic disease in new borns [138]. 
However there is conflicting data on how IgG mediates this suppressive effect 
[139]. IgG could potentially inhibit antibody responses by masking antigenic 
epitopes from B cells or mediating rapid phagocytic clearance of antigen so 
that B cells never see it. Alternatively, IgG can mediate suppression of B-cell 
signalling via the FcyRIIB [140] The cytoplasmic domain of FcyRIIB contains 
immune-receptor tyrosine-based inhibitory motifs (ITIMs) that serve to 
dampen BCR signals when ICs co-ligate the BCR and FcyRIIB. 
Enhancement of immune responses by immune complexes could occur occurs 
in several ways: (1) by directly influencing B cell signalling; (2) by enhancing 
antigen presentation; and (3) through enhanced deposition of antigen on 
FDC. The mechanism is probably strongly influenced by the antibody isotype 
as this dictates which Fc or complement receptors the immune complex will 
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interact with. 1gM, which is highly efficient at fixing complement, enhances 
both primary antibody responses (all isotypes) and helper-T cell respones and 
the formation of memory responses [139]. 
Natural 1gM clearly has an important role in primary responses as in mice 
that have a targeted disruption in the secretory exon of 1gM (but have normal 
expression of membrane 1gM and other isotypes) maturation of the primary 
antibody response is delayed [141]. 1gM enhancement of antibody responses 
to SRBC depends on complement [142] and is mediated by complement 
receptors CR1 (CD21)and CR2 (CD35) [143] which are expressed by antigen 
presenting cells, B cells and FDC. Recently the first Fc receptor for 1gM has 
been described, Fca/ p.R [144]. This is an endocytic receptor that binds 1gM 
and IgA and can mediate the uptake of microbes. It is expressed on B cells 
and macrophages but it is not yet known whether it also has a role in 1gM 
enhancement of immune responses. 
IgG also mediates enhancement of antibody responses and certain IgG 
isotypes (IgGi and IgG2a in the mouse) can activate complement. However, 
FcR common-'y chain deficient mice (which have a normal complement 
system) fail to respond to IgGi-antigen and IgG2a-antigen complexes [145], 
indicating that Fc receptors are responsible for this effect. The diverse Fc 
receptor family can be broadly divided into two categories: inhibitory and 
activatory. The inhibitory receptors are widely expressed on immune cells, 
whereas the 7-chain containing activatory Fc receptors - FcyRI, FcyRIII and 
FcER1 - are not expressed on lymphocytes. The y-chain, which is required for 
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both the surface expression and signalling function of the activatory Fc 
receptors, contains immune-receptor tyrosine -based activation motifs 
(ITAMs). Fc'yRl and FcER1 are high affinity receptors and can bind 
monomeric IgG and IgIE respectively. Fc'yRIII is lower affinity and can only 
bind IgG that is in the form of multimeric complexes with antigen. These 
receptors have well-defined functions in the effector phase of the response, 
such as mast-cell degranulation and anti-tumour cytotoxicity [140]. However, 
their regulatory role in the afferent response is not clearly understood. In 
vitro, antigen delivered specifically to Fc'yRl on dendritic cells will induce DC 
maturation and will be targeted to the MHC class I presentation pathway 
[146], but the physiological significance of this is not known. Manser's group 
reported that although FcR 'y chain -I- mice have enhanced deposition of 
immune complexes on FDCs (due to defective IC clearance) they have normal 
antibody responses [147]. However, more recently, another group found that 
these mice have diminished TD antibody responses and delayed-type 
hypersensitivity (DTH) responses [148]. In addition, it has been reported that 
cross-linking of this receptor on macrophages in vitro leads to the induction of 
the anti-inflammatory cytokine IL-10 and suppression of IL-12 secretion [149]. 
And so antibody, via FcyRl, may play also a role in down-regulating 
inflammation. 
1.18 Aims of this study 
The broad initial intention of this study was to further characterise the cellular 
basis of memory in antibody responses. Antigen binding was used to identify 
those cell types in the lymphoid tissues of mice that may be involved in B cell 
memory. In doing so, a novel antigen capturing non-B cell was uncovered and 
we have investigated both the mechanism of antigen capture and potential 
regulatory roles of this cell in the context of T and B cell memory. In addition, 
I set out to examine the requirement for CD40 signals in the generation of 
IgM B cell memory. This line of enquiry was prompted by the earlier 
findings of this research group, that secondary 1gM responses were 
unaffected, and perhaps enhanced, following blockade of CD40-CD154 
signals by a CD40-Ig fusion protein. Interest was further fuelled by the 
discovery of an IgM memory B cell subset in mice and humans. 
Chapter 2: A novel surface lgG antigen-binding cell 
Introduction 
Studies of memory B cells in mice have been limited by the lack of a 
definitive surface marker. By immunising mice with the highly fluorescent 
protein phycoerythrin (PE) two other groups have successfully detected high 
affinity, PE specific, memory B cells by FACS [150], [118]. These previous 
studies focussed on classic CD19IgD-IgM memory B cells. However, it has 
become clear that B cell memory is an emergent property of a diverse 
collection of cells, including non-class switched cells [121], [120], [123]. Other 
non-B antigen binding cells, namely FDCs, are also thought to influence the 
generation and maintenance of B cell recall responses [151], [152], [153]. We 
employed the PE immunisation method of detecting antigen-reactive cells 
with the intention of further characterising the cellular compartments that 
contribute to B cell memory. We discovered the dominant antigen-binding 
population in the memory phase of the response to be an unusual myeloid 
cell type, which lacks distinct lineage markers. This population has 
apparently not been described before. No evidence was found of the B220 
memory B cell that has recently been reported [116], [117], although they 
would seem to closely resemble the myeloid cell we describe. The possibility 
that other groups have mistaken a myeloid antigen-capturing cell for a 
memory B cell is discussed. 
Results 
2.1 	Two distinct antigen-binding compartments 
2 weeks following intraperitoneal (ip) immunisation with PE and pertussis, 
spleen and bone marrow were harvested. Cell suspensions were stained with 
PE and a mAb against the B cell differentiation marker B220 and analysed by 
flow cytometry (Figure 3A). By the addition of PE we can detect the PE 
binding cells. Background PE staining in unimmunised mice is minimal in 
the B220- compartment (0.00 - 0.02%) with more variable, slightly higher 
levels on the B220 compartment (0.01 - 0.08%). As described previously, a 
population of B220 PE cells are clearly visible in the spleen at this day 14 
time point (0.54% of total spleen). At this early time point, these are probably 
mostly PE-specific, affinity matured, germinal centre B cells, although there 
will also be some memory cells and AFC in the spleen. Unexpectedly, we 
also see a distinct second population of PE-binding cells in the spleen which 
are B220- (0.25%). These cells are not mentioned in the previous PE 
immunisation studies, or in studies of hapten-specific B cells - where a 
fluorescent hapten conjugate was used to detect antigen specific B cells by 
FACS [104], [86]. In the bone marrow there is also a B220- PE population 
(0.54% of total white cells), which is the major PE-binding cell type at this 
site. Occasionally there is also a low level of B220PE cells just detectable 
above background levels in the bone marrow, although this varies from 
mouse to mouse. 
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Figure 3 
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Spleen and bone marrow cells from an unimmunised mouse and a PE immunised 
mouse, day 14, were stained for PE binding activity and B220 expression. Plots are gated 
on live white cells. In each case bone marrow and spleen are from the same mouse. 
Percentages of B220PE and B220- 
 PE populations (box gates) of total white cells are 
shown above each gate. There is minimal background PE staining in the unimmunised 
mouse. Results shown are representative of at least 5 mice. B. B220PE and B220 PE 
cells were backgated to show their forward scatter (FSC), x-axis, and side scatter (SSC), y -
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CD40 ' (on B6 background) and C57BL/6 mice were immunised with PE. 3 
weeks later spleen and bone marrow were harvested and analysed for B220 
expression and PE binding activity by flow cytometry. In the plots above 
B220 is on the x-axis, PE on the y axis. The results show spleen and bone 
marrow are from I C5713116 
and I CD40' mouse, as labelled. There were 2 
mice in each group. 
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We know the generation of both B220 and B220 PE binding populations is 
dependent on T cell help as neither population emerges in CD40+ mice 
(Figure 4). 
2.2 Antigen-binding properties 
Figure 3A shows that B220 and B220 PE-binding populations differ in their 
antigen binding capacity. The splenic B220 compartment appears 
heterogeneous in this respect with a wide range of PE staining intensities. 
This would be expected of an oligoclonal B cell population at different stages 
of activation, which would express variable levels of Ig of differing affinity 
(i.e. avidity differences). By comparison the B220 compartment in the 
spleen and bone marrow is very homogenous, the range of PE staining 
intensities is narrow and of relatively intermediate level (Figure 3A). 
Comparing between mice we found that while FE staining intensity of B220 
cells is always within a narrow range, the MFI (mean fluorescence intensity) 
of this range can vary greatly, by as much a log, between individual mice 
from the same cohort. 
2.3 	Light-scatter properties 
B220PE cells fall within the normal lymphocyte gate, as expected of B cells, 
whereas B220-  PE cells have a have higher side scatter (SSC). Figure 3B. This 
indicates that these cells are more granular than normal lymphocytes. As the 
normal lymphocyte gate excludes the B220 antigen binding cells, this could 
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be one reason why they have not been described before in flow cytometry 
studies of antigen-specific B cells. 
2.4 	B220- 
 antigen-binding cells are maintained for long periods 
The frequencies of both B220 and B220 1 
 antigen-binding cell types were 
measured at various time points after immunisation. In the spleen B220PE 
cells peak in frequency at around 3 weeks and decline rapidly thereafter. By 
8 weeks they are undetectable above background (Figure 5). B220 PE cells 
also reach their maximal frequency at around 3 weeks, but their numbers fall 
only slightly and they stabilise at an average of 0.4% in the spleen and 0.6% 
in the bone marrow. These frequencies are maintained in the spleen and 
bone marrow for at least 6 months following immunisation (Figure 5). As the 
percentage of B220PE cells after 8 weeks falls below the background levels 
of PE staining on unimmunised spleen, we would not be able to use this 
system to study classical B220CD19 memory B cells. However, 
interestingly a previously undocumented population of long-lived B220 
antigen capturing cells had been uncovered. This cellular compartment could 
be detected undiminished, long into the quiescent memory phase. Moreover, 
the locality of these cells in the major sites of recall and long-lived antibody 
responses the spleen and the bone marrow. Together this implied a possible 
role in B cell memory. 
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Decay of B220PE and B220 PE cells over time 
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At various times after PE immunisation, up to 180 days, the percentages of 
B220PE cells in the spleen (A) and B220- 
 PE cells in the spleen (B) and bone 
marrow (C) were measured by FAGS. Each point plotted represents a single mouse. 
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Figure 6 	
phenotyping of PE+ cells by FAGS (part I) 
A B220-PE+ B B220-PE+ C B220+PE+ 
spleen 	bone marrow spleen 
syndecafl-1 
(281-2 rat y2a) 
CDI9 
(103 rat y2a) 
CD2I 






(S7 rat y2a) 
Three colour FAGS 
analysis was used to assess the expression of various 
markers on B220 PE cells and B220PE 
from PE immunised mice 2-5 
weeks after primary immunisation. Spleen and bone marrow cell 
suspensions were stained with (I) B220 FITC or B220 
PerCp; (2) PE and 
(3) 
an antibody against the marker of interest, either directly conjugated to 
FITC or biotinylated, in which case streptavdin-FITC or streptavidin-CyS was 
used as a secondary reagent. B220 PE 
populations in the spleen (column 
A) and bone marrow (column B) and B220PE 
populations in the spleen 
(column C) were gated, as in Figure IA. In each panel the expression of the 
indicated marker on the gated population is shown in blue against that of 
either the whole spleen (A, C) or bone marrow (B) 
in the same staining. 
(Continued overleaf). 
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A B220-PE+ B B220-PE+ 	
C B220+PE+ 
spleen 	bone marrow 
CD45 
CDIIb 





(GK1 .5 rat y2b) 
CD8 
(53-6.7 rat 'y2a) 
In each panel the spleen and bone marrow staining are from the same 
mouse. Profiles are representative of at least 3 mice analysed. There were 
intrinsic isotype controls (isotype of each MAb given). E.g. CDI9 is an 
isotype control for CD43. See FIG 13 for hamster lgG isotype control. 
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2.5 B220-  antigen-binding cells are IgG 4 
 but lack other B lineage markers 
There were several candidate identities for the B220 -  PE cells. Potentially 
they were PE-specific plasma cells (which are known to down regulate B220), 
or a novel memory-lineage B cell that no longer expresses B220. 
Alternatively, they could be macrophage or FDC-like cells that can capture 
antigen via secreted antibody that is bound to its surface by Fc or 
complement receptors. Phenotypic analysis by FACS showed that B220 - PE 
cells have IgG antibodies on their surface but lack 1gM (Figure 6). In addition 
they lack expression of the B cell co-receptors CD19 and CD21 whereas 
B220PE cells in the spleen express both of these receptors. Plasma cells are 
also known to down-regulate these receptors, however, the B220 PE cells do 
not express the plasma cell marker syndecan-1 (Figure 6). 
In addition, they were negative for expression of the T cell lineage markers, 
CD4 and CD8. However, they were found to express low to intermediate 
levels of the integrins CD11b (Mac-1) and CDlic (Figure 6). CD11b is often 
used as a macrophage-lineage marker, but it is also expressed by a subset of 
dendritic cells, the myeloid DCs, and by Bi cells. CD11c is expressed at high 
levels by several DC subsets in the spleen but there have been no reports of 
its expression on B cells. Although lacking the B220 CD45R isoform, B220 
PE cells do express CD45, as shown by staining with mAb YW62.3, which 
recognises all CD45 isoforms. The expression of this pan-leukocyte marker 
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indicates this cell is likely to be of haematopoietic rather than stromal cell 
origin. The adhesion molecule CD43 is absent on mature B cells; B220 PE 
cells express high levels of CD43. A summary of the phenotype of B220 PE 
cells compared with B220PE cells is given in Table 1. 
Table I 	Phenotyping of B220- 
 PE cells by flow cytometry (part I) 
surface marker B220- PE B220PE 
distribution 
+ mature B cells 
CD19 - 
+ mature B cells 
CD21 - 
Syndecan-1 - /- 
plasma cells 
1gM - '7.. 
all B cell stages 
+ / 
activated and memory B cells 
lgG 
- Helper T cells, DC, M4 
CD4 - 
- cytotoxic T cells, DC, yöT cells CD8 - 
CD1Ib + (med) 
- macrophages, Bi cells 
CD1Ic + (low) 
- dendritic cells 
+ most leukocytes 
CD45 + 
++ T cells, immature B cells, CD43 plasma cells, M4, DC 
56 
Figure 7 	Rechallenge of PE immunised mice 
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136 mice were primed with PE then rechallenged with PE in the absence of 
adjuvant, 6 weeks later. At 0, 4 and 9 days after immunisation mice were 
killed and spleen and bone marrow stained for B220 and PE-binding. Two 
mice were taken at each time point. Plots show staining from a single mouse 
from each group. The size of the gated 13220 PE population is shown as 
percentage of total cells. Following immunisation the background level of PE 
staining increases on 13220 and 13220 populations, but the level of PE 
staining on the 13220 PE population increases also so they still be clearly 
distinguished above background. 
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2.6 The B220 PE compartment does not expand in response antigen 
One defining functional characteristic of a memory cell is rapid proliferation 
and differentiation to effector cell function in response to antigen. In two 
separate experiments where PE immunised mice were re-challenged no 
expansion of B220 PE cells was seen over 7 days (Figure 7). On the opposite 
pole, there was no initial depletion of the population, as might be expected if 
there was mass differentiation to effectors. So, if the B220 - PE cells are 
memory B cells they are either refractory to antigen, or the population is 
under extremely tight homeostatic control - where exit of cells is balanced 
precisely by replenishment. However, the PE-binding capacity of the 
PEB220 population does appear to increase on rechallenge. If we assumed 
these cells were B cells, experiments involving adoptive transfer of sorted 
PE subsets into naïve hosts would be required to resolve this issue. 
However we had not yet shown definitively whether or not these were B 
cells. 
2.7 B220 antigen binding cells can capture more than one antigen 
Given the results described so far, I suspected that the B220 PE cells were 
not B cells at all but rather a cell that binds antibody and antigen non-
specifically. If this were the case, the cells should be able to catch more than 
one antigen. A memory B cell, on the other hand should be mono-specific. To 
























Spleen and bone marrow were harvested from 3 mice which had been immunised 4 
weeks before with: (1) APC alone (2) PE alone (3) APC and PE together. Cells were 
stained with anti-CID 19 mAb, PE and APC and analysed by FACS. Plots in B show 
PE (x axis) and APC (y-axis) binding of CDI9- cells (gate R3 in A). This experiment 
was repeated once more and these results were replicated. 
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Mice were immunised with either (1) PE alone, (2) allophycocyanin (APC) 
alone, or (3) both PE and APC together. After 4 weeks spleen and bone 
marrow cells from these mice were stained with both PE and APC. In the 
double-immunised mice all the B220-  PE cells are also APC + and, vice-
versa, all the B220 APC cells are also PE (Figure 8). PE cells from PE 
single-immunised mice do not also bind APC, and conversely APC cells 
from APC single immunised mice do not also bind PE. This shows there is no 
antigenic cross-reactivity between these two fluorescent proteins, nor any 
non-specific binding. Therefore, we conclude from this experiment that the 
B220 antigen binding cells in the spleen and bone marrow are not mono- 
specific and so cannot be memory B cells. It would appear that by binding 
secreted serum IgG to their surface, these cells could capture whichever 
antigens the animal has been immunised with. 
2.8 Transfer of anti-PE sera 
To demonstrate that B220 PE cells bind antigen by way of serum Ig, we 
asked if antigen-specific binding could be transferred with sera. 200.11 of 
serum, taken from a PE immunised mouse 4-7days after secondary 
challenge, was transferred intravenously (iv) into unimmunised wild type 
and or RAG-/ -  mice, in which there is no serum antibody. 36 hours after 
transfer the spleen and bone marrow were harvested and analysed. A B220 




















To test whether PE binding activity can be transferred by anti-PE sera, 
unimmunised C57BL16 or RAG -- 	were given two iv injections of 200p.l 
sera from a PE immunised and boosted mouse. The 2 nd  injection was given 
24h after the first, and mice were killed 18h later along with a positive control 
PE immunised mouse. Spleen and bone marrow were analysed by FACS for 
B220 and PE binding. (A) PE immunised C57BL16; (B) unimmunised 
C57BL16, given sera; (C) unimmunised RAG', given sera. 
61 
The frequencies of this population in both mice are comparable to the 
corresponding population in PE immunised mice (Figure 9). As RAG-I - mice 
lack mature lymphocytes, this experiment also shows that B220- PE cells are 
not derived from the T or B cell lineage and must therefore be of myeloid 
origin. This experiment also demonstrates that the development of these 
antigen-capturing cells is not dependent on factors produced by T or B cells, 
unlike FDCs for example which do not develop in the absence of B cells [154]. 
In two separate experiments we were surprised to detect, in addition to 
the B220- PE cells, a small but significant population of B220PE cells in 
unimmunised wild-type mice that had received anti-PE sera. We are not sure 
why this is. It may be that there were some residual immune complexes in the 
sera of the donor which had not been cleared and these were bound by 
FcyRIIB and the complement receptors, CR1 and CR2, expressed on the 
recipient B cells. Whatever the mechanism, this result suggests that some of 
the B220PE cells seen during the early phase of the FE response may be not 
actually be FE-specific B cells. 
Discussion 
We were interested in studying the maintenance phase of memory and so 
needed a means of recognising antigen specific B cells in the quiescent phase 
of the response. We can detect B220PE+ cells up to 8 weeks after FE 
immunisation. However, at this time point, by histology, we can still see the 
remnants of FE specific germinal centres in the spleen. Other groups have 
reported that germinal centre B cells can be detected for at least 80 days post 
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immunisation [86]. Due to background levels of non-specific PE binding in 
the B cell compartment, B220PE cells cannot be reliably identified after 8 
weeks. Therefore, we concluded we would not be able to use this system to 
study true resting memory B cells. However, Rajewsky and co-workers have 
used this system to study the turnover of memory B cells at up to 6 months 
after immunisation [118]. They appear to get around the problem of non-
specific PE binding in the B cell compartment by pre-enriching for B220IgM-
IgD-PE cells before further analysis by FACS. Such an enrichment step is not 
practical for a study involving many samples and limits the scope of 
investigations to a single B220IgG B cell population. 
However, we have found a population of antigen binding IgG cells that 
appear within the first 2 weeks of immunisation and are maintained at stable 
frequencies for long periods. The experiments described here show that these 
are not memory B cells or even B cells, rather they masquerade as memory B 
cells by binding serum IgG to their surface. This explains why they are so 
different from B220PE cells in their antigen binding activity. Presumably 
qualitative differences in anti-PE IgG production, and total background IgG 
levels between mice account for differing levels of PE binding by B220 PE 
populations from mouse to mouse. 
Finding this cell demonstrates that the combination of antigen-binding 
activity and surface IgG expression cannot be reliably used to identify 
memory B cells. Subsequent to the initiation of this work there have been two 
published reports of a novel B220- memory B cell [116], [117]. In light of 
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results presented in this chapter it is necessary to re-examine these reports in 
detail, to establish whether it can be confidently ruled out that these novel B 
cell compartments may actually be partly or wholly attributable to the non-B 
antigen capturing cells we have described. 
Dealing first with the initial report from Wabl et al.; this involves the "knock 
in" quasi-monoclonal (QM) mouse in which the majority of B cells are specific 
for the hapten nitrophenyl (NP) [155]. To create the QM mouse a rearranged 
V-D-J gene segment was inserted, by homologous recombination, into one of 
the Ig heavy chain alleles. This was then bred on to a K-I-  Ji-r/ -  background. 
The combination of the inserted VDJ heavy chain paired with any of the 
remaining ?. light chains produces an Ig molecule that is specific for the 
hapten nitrophenyl NP. Thus the majority of B cells are specific for NP. 
Transgenic B cells can be identified using either fluorescently labelled NP or 
an anti-idiotype (Id) antibody. For reasons that are not clear, QM mice 
spontaneously make anti-NP IgG antibody responses and in the recent study 
the authors identify an IgG B220- Id cell in the peripheral blood of QM mice 
[116]. They go on to show that this cell is IgG but does not express 1gM, 
CD19 or syndecan-1. As somatic hypermutation of V genes is regarded as the 
definitive marker of B cell memory, B220- Id cells were FACS sorted and the 
NP-specific heavy and light chains were specifically amplified and sequenced 
by an RT-PCR method. The authors can produce mutated sequences from 
these cells and so they conclude: 
"While the B220- cells still could have picked up Ig from the serum they make 
cytoplasmic L chain (not shown) and produce (mutated) mRNA encoding 
both H and L chain; therefore they are, by definition, B cells." 
In many ways these B220- Id cells resemble the B220 PE cells, which we 
have also found in the peripheral blood. So what of the proof that these are B 
cells? We have not stained the B220- PE cells for cytoplasmic Ig and it is 
difficult to question data that is not shown. However, just as the Ig on the 
surface of certain cells may not be endogenously derived, Ig in the cytoplasm 
may have been ingested in the form of immune complexes. Finding this 
activity in a cell that can bind serum Ig would not be surprising. 
More persuasive is the evidence given that the B220- Id cells express 
mutated V genes - until we examine the method used to extract these 
mutated sequences. B220- Id cells were FACS sorted and the authors do not 
give the purity of this sort but do tell us it was not 100%. cDNA made from 
the sorted cells was extensively PCR amplified with primers specific for the 
inserted VH segment and the endogenous VL ?. genes. Even if there were just a 
small number of contaminating QM plasma cells (which would also be B220-
Id), these cells produce relatively huge amounts of Ig mRNA - which could 
easily produce positive PCR products. Although we now know that B220- PE 
cells are not B cells, we found we could amplify a sizeable IgGi RT-PCR 
product from both B220PE and B220- PE FACS sorted cells (where the 
purity was estimated to be 95%). Thus, producing mutated V gene sequences 
from B220- Id cells by this RT-PCR method cannot be taken as proof that 
these cells are memory B cells. 
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One aspect in which the B220 Id cells would appear to differ from 
B220- PE cells is CD11b expression. We found the B220- PE cells in the 
spleen and bone marrow expressed low to intermediate levels of this integrin, 
whereas the B220- Id cells are CD11b-. So we may not be describing the same 
cell-type. As QM mice spontaneously produce anti-NP IgG there may well be 
chronic differentiation of naïve B220Id B cells to B220 10- Id activated B cells 
to B22010w/- Id plasma cells. (This could be an explanation for the dramatic 
reduction in the total number of B cells in the QM mouse). In this artificial 
system a B220- /10w  Id + intermediary stage may well appear to be a stable 
memory population. It is interesting to note in this respect that B220- Id cells 
were found in the peritoneum of the QM mouse. Bi cells, which have an 
activated phenotype predominate at this anatomical location and instead of 
discrete B220- and B220 Id populations, there was a continuum of B220 
expression, from very high to completely negative. Thus illustrating the B cell 
activation pathway. 
In the more extensive study by McHeyzer-Williams and co-workers, 
mice were immunised with NP-KLH and then antigen-specific cells were 
detected by a NP-fluorophore conjugate. Only after primary immunisation 
with 400pg of antigen in Ribi adjuvant, followed 8 weeks later by a secondary 
identical challenge, were they able to detect a B220- NPIgD-syndecan-1 - 
population in the spleen and bone marrow. They describe this as a novel 
memory B cell compartment, which can be divided into 2 subsets based on 
IgE expression. They find this novel B220- memory population to be the major 
memory compartment in the spleen and bone marrow. There are four main 
pieces of evidence supporting this conclusion. 
(1) First, they RT-PCR amplify VX genes (the antibody response to NP 
in the B6 mouse is dominated by ?. Ig) from sorted B220- NP syndecan single 
cells, and obtain sequences that are mutated. By sorting single cells they avoid 
the plasma cell contamination mentioned in the discussion above. However, 
they do not give an indication of the accuracy of this sorting procedure and, 
worryingly, they obtain a positive V2. PCR product from only 15% of samples. 
By comparison 60% of B220+ memory cells give a positive product. 
(2) Second, and more compelling are adoptive transfer experiments where 
FACS sorted NPB220- or NPB220 populations are transferred together with 
helper T cells into RAG-/- mice. Surprisingly, they show that B220- NP and 
B220NP cell populations can give rise to all 3 types of antigen binding cell: 
B220-, B220 and B220-/ syndecan; but only when antigen is co-transferred. 
It appears that unlike NPB220 classical memory cells, NPB220- cells do not 
survive transfer at all in the absence of antigen. The interpretation of these 
results is that there is a population B220- memory B cells which, in the 
presence of antigen, can be derived from B220 memory B cells and form a 
long lived self-replenishing pool. Moreover, when stimulated by antigen, this 
B220- pool can in turn give rise to not only plasma cells, but to classical B220 
B cells. It is not obvious how this fits with the current picture of memory B 
cell differentiation. 
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One problem in the design of this experiment, which possibly contributes to 
the confusing results, is that the transfers are carried out at 4 days and 42 days 
after secondary immunisation with adjuvant and a large amount of antigen 
(400p.g). The authors do not show that the putative memory cells are resting, 
and it is likely that a number of them are recently activated, transitory B cells 
which have not yet fully differentiated to plasma cell. An adoptive transfer of 
cells taken several months after only a primary dose of antigen (within the 
more usual 50 - IOOp.g range) would be a truer test of memory. 
In an earlier study (before a B220- memory cell had been proposed), 
Radbruch's group separated B220- and B220 bone marrow populations from 
3 month post OVA immunised mice and transferred them, with adequate T 
cell help, into naïve hosts [110]. In the recipients of B220- bone marrow, serum 
titres of anti-OVA IgG steadily rose due to the transfer of long lived plasma 
cells then plateaued, but in the recipients of B220 bone marrow no serum 
anti-OVA IgG was detected. However, when antigen was co-transferred, the 
B220 recipients rapidly produced an anti-OVA IgG response due to the 
activation of transferred B220 memory B cells. Notably, the presence of 
antigen in the B220- recipients did not cause any increase in the specific IgG 
titres. These experiments were designed to test if long lived plasma cells 
required, or were responsive to antigen. They also argue against the existence 
of a B220- memory cell in the bone marrow. 
(3) Thirdly, the authors do not detect a B220- NP population upon 
transfer of 50tl of immune sera into RAG-I- mice, thus arguing against passive 
binding of serum Ig by these cells. However, we find that transfer of 2x 200tl 
of anti-PE serum into RAG -I- mice did allowed detection of B220- PE cells. In 
one experiment where only 100 jtl of serum was transferred into an 
unimmunised wild type mouse we failed to detect the cells, implying the 
level of specific Ig transferred is critical. In this respect it is interesting to note 
that McHeyzer-Williams and co-workers only detect the B220- NP cells on 
secondary challenge, this may be because levels and/or affinity of NP-specific 
Ig in the serum are too low to allow detection after just the primary response. 
(4) Finally, the authors find that one subset of B220- NP cells, the IgE-
subset, expresses the BCR signal transducer CD79b (Ig-P). CD79b along with 
CD79a (Ig-a) associates with the BCR and this pair are essential for BCR 
signal transduction [156, 157]. These molecules have only been found on B 
lineage cells - therefore, the IgE-CD79b subset must be a B cell population. 
Conversely, the IgE CD79b- subset is unlikely to be an antigen-responsive B 
cell population as CD79b is absolutely required for B cell activation through 
the BCR. The authors did not differentiate between CD79b and CD79b-
subpopulations in their assessment of the numbers of B220- memory cells or 
in the adoptive transfer and V gene sequencing experiments. 
Our B220- PE cell most closely resembles the B220- NPIgE cell 
described by McHeyzer-Williams, which is also CDllbt However, FACS 
data showed B220 PE cells to be IgG. This was with a polyclonal antibody 
that does not stain the majority of B cells, and so it presumably does not cross-
react with 1gM or IgD. This antibody may, however, cross-react with IgE, and 
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so it would be informative to stain with monoclonal antibodies against 
specific IgG subclasses and IgE. B220-/low antigen binding B cells most 
certainly form a transitory stage in B cell differentiation to plasma cells. We 
would expect to detect such cells, in certain situations, during the induction 
phase of a response, which can last for many weeks. Occasionally a B220 10' 
PE population can be discerned in PE immunised spleen. However, for such 
a cellular stage to be considered a memory cell it would need to be shown to 
persist and to carry memory function in the quiescent phase. In this respect 
there seems to be little evidence for a B220- memory cell in the literature. 
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Chapter 3: More about the antigen-capturing cell 
Results 
3.1 PE binding is independent of complement and requires FcyRl 
The binding of secreted Ig to a cell surface is mediated by a diverse group of 
receptors. Monomeric IgG is bound with high affinity by only two members 
of the Fc receptor family - Fc'yRl and FcRn. On the other hand, immune 
complexes may be bound by most Pc receptors or by complement receptors, 
which recognise C3 and C4 cleavage products deposited on immune 
complexes [158]. To determine how B220- antigen capturing cells acquire 
antibody, a panel of mice with targeted genetic deficiencies in one or more 
Ig-binding mechanism were immunised with PE, then analysed 3-4 weeks 
later for B220- PE binding cells. The targeted genes and resulting immune 
phenotypes are summarised in Table 2. Note that in these experiments CD19 
and B220 have been used interchangeably to define the 2 antigen-binding 
subsets. 
Two different complement deficient mice were available to us, C1q/- and 
C2/BF-/- mice. There are three distinct routes that can lead to activation of 
the complement cascade: the classical pathway, the alternative pathway and 
the lectin pathway. Clq which recognises antibody that is complexed with 
antigen, initiates the classical pathway, thus Clq-/- mice have a complete 
defect in classical complement activation. As a result these mice have 
deficient immune complex deposition on FDC [159]. C2/BF-/- mice lack two 
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critical complement components: C2, which is required for the classical and 
lectin pathways, and factor B, which is required for alternate pathway 
activation [160]. Normal frequencies of B220- PE cells were found in the 
spleen and bone marrow of both Clq-/- and C2/ BF -I- mice; thus excluding a 
requirement for complement in Ig binding by these antigen capturing cells 
(Figure lOB). 
Table 2 	PE immunisation of knock out mice deficient in lg binding 
mechanisms 
Knock out mouse 	 Phenotype 	CDI 9-PE 	CDI 9PE 
2 microglobulin 	No MHC class I or FcRn or 
CD8 T cells 
Clq ' 	 No classical pathwayl 
complement activation 
C2/13F . 	 no alternative or classical 
complement pathway 
Fc'yRlIl ' 	 no FcyRlll 
FcR y chain ' 	no Fc'Rl, FcyRlll or FcER1 
(enhanced immune 
complex deposition on 
FDC) 
+ 	 + 
+ 	 + 
+ 	 + 
+ 
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Figure 10 	PE immunisation of mice deficient in antibody binding 
mechanisms 
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In three separate experiments (A,B and C) wild type and "knock out" mice 
were immunised with FE. Spleen and bone marrow were harvested 3-5 
weeks later and analysed by FACS for CD1 9 or 8220 expression, and FE 
binding activity. Bar charts A-C show the mean percentage B220- or CD1 9-
PE cells with error bars showing plus 1 SD, n=3. (A) B220- PE cells in 2m 
and C57BL16 mice (B) B220- PE cells in C1 q -/- , BF/C2t FcyRlll and 
C57BL16. (C) CD19-PE cells in FcR y chain and C57131-6. (D) 
Representative FACS plots from FcR y chain and C57BL16, spleen and 
bone marrow. 
73 
There are four known FcRs that can bind IgG: FcyRI, FcyRIII, Fc7RIIB and the 
neonatal FcR (FcRn) [158]. Fc'yRIIB is the only Fc receptor expressed on B 
cells, where it has a role in regulating BCR signals. We did not consider this 
receptor, as the B220- ACC subset did not bind the monoclonal Ab 24G2 
(data not shown) but the three other receptors were investigated. In foetal 
and neonatal life FcRn mediates the transfer of maternal IgG across the 
placenta and the gut wall respectively. It also has a general role throughout 
life in maintaining serum IgG levels by protecting IgG molecules from 
degradation [161]. FcRn is a member of the MHC class I protein family and 
forms a heterodimer with f32nlicroglobulin (132m) - 132m -/ - mice, therefore, do 
not express this receptor. Following PE immunisation, we found 132m / mice 
have normal frequencies of B220- PE cells in the spleen and bone marrow 
(Figure bA). 
FcyRl (CD64) and FcyRIII (CD16) are multimeric receptors that use the same 
signalling subunit - the FcR common y  chain. This subunit is required for 
the surface expression of both receptors. FcyRIII is has low affinity for 
monomeric IgG receptor, but bind complexed antibody with high avidity, 
and it is expressed only on myeloid cells. Fc'yRIII-/- mice were found to have 
B220- PE cells in the spleen and bone marrow (Figure lOB). While the 
frequencies of B220- PE cells in the bone marrow of Fc'yRIII-/- mice are 
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comparable to those in wild type C57BL/6 mice, there appears to be a 
reduced frequency of B220- PE cells in the spleen of FcyRIII-/- mice. However 
group numbers (n=3) are too low to establish if this is a significant difference. 
FcyRl-/- mice are not yet available and so to look at the involvement of FcyRl 
we examined mice that lack the FcR common y  chain. These mice cannot 
express FcyRIII, Fc'yRI (CD64) or the high affinity IgE receptor FcR1. FcyRI is 
the highest affinity IgG receptor and can bind monomeric IgG. FcR y chain -I-
mice were found to have a complete absence of B220 PE cells in both the 
spleen and bone marrow (Figure lOG). These mice do have a normal 
population of B220PE cells, indicating the B cell response to FE is not 
affected. Our later studies of serum anti-FE antibody responses in FcR y 
chain / mice confirm this (Chapter 4). Therefore, it is unlikely that the 
absence of B220- PE cells is due to a defect in anti-FE antibody production. 
As we have already ruled out a requirement for FcyRIII, the absence of B220 
PE cells in the FcR y chain -I- mice is most probably due to the lack of FcyRI. 
Unfortunately there is no commercially available mAb that 
specifically recognises mouse CD64, and so we are unable to confirm directly 
that this receptor is expressed on B220- PE cells. Our FAGS data (Figure 6) 
indicated that the B220- PE cells bind IgG, however, we have not checked for 
surface binding of IgE. It is possible that FcR1 and IgE may also contribute 
to the antigen-capturing activity of B220- PE cells. Given the results of 
McHeyzer-Williams and co-workers [117], discussed in Chapter 2, this 
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possibility should be investigated. However, further discussion here will 
focus on IgG and FcyRl. 
3.2 B220 PE antigen -capturing cells are rapidly dividing 
By flow cytometry, a B220 - PE antigen capturing population can only be 
detected following ex-vivo staining with PE. Therefore, it is most likely that in 
vivo these cells are binding monomeric 1g, rather than Ig-PE immune 
complexes. In agreement with this, FcyRl can bind monomeric IgG. As the 
antigen capturing population is maintained for long periods after 
immunisation, we sought to determine whether these were long-lived cells 
(in which case the IgG on their surface may have been captured early in the 
response) or self-replenishing cells (in which case the IgG on their surface 
will have been acquired recently). 
The incorporation of the thymidine analogue BrdU can be used as an 
indicator of cells that have undergone DNA replication in vivo [37]. Cells that 
enter S-phase when BrdU is present incorporate it into their DNA and this 
can be detected by an anti-BrdU mAb. At various times after PE 
immunisation, mice were given a 4 day pulse of BrdU in their drinking water 
and then killed. Spleen and bone marrow were harvested and analysed, by 
flow cytometry, for BrdU content and PE binding. The anti-BrdU mAb is 
FITC labelled and I intended to use anti-B220- PerCP to differentiate B220-
PE and B220PE populations, however, PerCP fluorescence does not 
survive the fixing method required for BrdU staining. Therefore, at the 3 
,I1 
week time point analysis, PE cells in the spleen are likely to include a 
proportion of B220PE B cells. In the bone marrow and at later stages in the 
spleen, numbers of B220PE cells are negligible (0.00 - 0.03% of total cells). 
At 3 weeks more than 90% of PE cells in the spleen and bone marrow were 
found to be BrdU after 4 days (Figure 11). The percentage of PE cells that 
are BrdU' seems to be relatively stable in the spleen up to 12 weeks. In the 
bone marrow there is apparently a gradual decline in the level of turnover 
and after 6 months only 50% of PE cells in the bone marrow are BrdU. 
However, this is still a high level of turnover. By way of comparison, 12 
weeks after immunisation only 9% of splenic B cells have incorporated BrdU 
in 4 days. The high level of turnover within the PE capturing population 
implies this cell population cannot be retaining IgG on their surface for long 
periods of time. Therefore, the IgG on their surface at later time points, for 
example 12 weeks after immunisation must have been recently produced by 
long-lived plasma cells. 
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At 3, 8, 12 and 27 weeks after PE immunisation mice were given BrdU in 
their drinking water for 4 days then killed. Spleen and bone marrow were 
analysed by FACS for PE binding and BrdU incorporation. B220 cells in the 
spleen were also analysed for BrdU incorporation at 3, 8 and 12 weeks. (B) 
Typical BrdU/PE FAGS profile (from bone marrow at 8 weeks). (A) 
Percentage of PE cells in the speen and bone marrow that are BrdU + after 
4 days, at various times after immunisation. Each point represents an 
individual mouse with a line showing the mean value of each group. 
3.3 Morphology of B220 PE cells 
FcyRl can be expressed by macrophages, dendritic cells, monocytes, 
eosinophils, basophils and neutrophils [162]. These cell types have distinctive 
morphologies and so, to assist in characterising B220- PE cells, cytospins of 
FACS sorted B220 PE bone marrow cells were stained with haemotoxylin 
and eosin dyes. Figure 12 shows that B220- PE cells are mononuclear, 
neutrophilic cells that are larger than lymphocytes. Their cytoplasm is 
slightly granular and the nucleus often appears indented, a characteristic 
typical of monocytes. These cells do not resemble classical lymphocytes, 
eosinophils, basophils, mast cells or neutrophils - overall their morphology 
is best described as monocyte-like. A dendritic morphology is not evident in 
this stain, although the aggressive sorting procedure would perhaps not 
preserve this. 
3.4 B220 PE cells express some markers associated with APCs 
One function of FcyRl is the targeting of antigen to MHC class I and MHC 
class II processing and presentation pathways [139], although the precise 
pathways are not understood. Surface expression of MHC class II molecules 
and costimulatory ligands such as CD81/86 and CD40 are indicators of APC 
function. Further flow cytometric analysis of B220 PE cells was conducted 
to see if this population carried any general markers of antigen presenting 














B220 PE cells were FACS sorted from the bone marrow of FE immunised 
mice. Cytospins of these sorted cells (A,B) and of whole bone marrow (C) 
were stained with haemotoxylin and eosin. B220 PE cells are most similar 
in size and morphology to monocytes. They are unlike lymphocyes (L), or 
PMNs (N). 
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APC sub-types. B220 PE cells were found to express variable (low to 
intermediate) levels of MHC class II and they are CD40 (Figure 13),In 
addition, they express high levels of MHC class I. The B220- antigen 
capturing cells have an ambiguous phenotype in that they express low levels 
of both a macrophage-like marker, CD11b, and a DC-like marker, CD11c. 
Although, ex vivo, they do not seem to have a dendritic morphology it is 
possible that they may be precursors of the CD11cCD11b myeloid DC 
subset. Macrophages, monocytes and dendritic cells are inter-related 
lineages, in addition there is much heterogeneity within these cell 
classifications. For example, there is no one phenotypic marker expressed by 
all DC at all developmental stages. However, there are MAbs which can be 
used to differentiate certain M and DC subtypes: the MAb F480 is widely 
used to identify macrophages; MAb 33D1 recognises an epitope expressed by 
myeloid dendritic cells [163] and MAb DEC-205 recognises a lectin expressed 
by the lymphoid/plasmacytoid DC subset. B220- PE cells were found to be 
F480 dull,  DEC-205- and 331D- (Figure 13), suggesting this cell type is perhaps 
more M4-like than DC-like. The non-classical MHC molecule CD1, which is 
expressed at high levels by cells with strong APC capacity, such as splenic 
DC and marginal zone B cells, [164], is only expressed at intermediate levels 
by B220- PE cells. 
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Figure 13 Phenotyping of B220 PE cells by FACS (part II) 
spleen 	bone marrow 
3-8 weeks after PE immunisation, 3 colour flow cytometry was used to 
analyse the expression of various M and DC markers on B220 PE cells in 
spleen (left panel) and bone marrow (right panel). The expression of the 
marker indicated is shown on gated B220 PE cells (blue histogram) 
overlayed with the expression by the whole tissue in the same staining 
(empty histogram). Each profile is representative of analysis of at least 3 
mice. 
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Although B220-  PE cells express low levels of some M markers, following a 
simple plastic adherence step (1 hour at 37 0C), they are enriched in the non-
adherent fraction (e.g. from 0.5% to 1.5%). Murine M are strongly adherent 
whilst DCs are non-adherent to plastic [164]. And so it is still not clear which 
haematopoietic lineage the B220 PE cells belong to. 
3.5 B220 PE cells do not exhibit macropinocytosis in vitro. 
Given the ambiguous phenotype of B220- PE cells we decided to investigate 
their potential function as APC. The most obvious approach would be to 
assess B220- PE cells for the ability to function as APC s for T cells in an in 
vitro asay. However, the low frequencies of these cells and the limitations of 
cell sorting technology available to us meant we were unable to purify them 
in sufficient numbers. Therefore, any further functional assessment of these 
cells would have to involve discriminating them by FACS. A key feature of 
immature dendritic cells is constitutive, rapid, non-specific uptake of antigen 
by macropinocytosis. [165]. A population of splenic PE cells (shown to be 
B220-) were tested for this activity, ex-vivo, using the fluorescent substrate 
FITC-dextran. Uptake of FITC-dextran was measured over 1 hour by FACS 
at 37°C and at 0°C, at which temperature macropinocytosis is inhibited. 
Figure 14 shows that the PE cells failed to take up FITC-dextran, whereas a 
EN 
proportion of the positive control cells, a heterogeneous population of bone 
marrow derived dendritic cells, did. 
3.6 B220 antigen-capturing cells from QM mice 
As discussed in Chapter 2, we suspected the B220- CD19- Idiotype cells in 
the spleen and bone marrow of QM mice were the same antigen capturing 
cells described here. As we had access to QM mice this would be a 
convenient source of antigen capturing cells. To test if these were indeed the 
same cell type QM mice were immunised with the fluorophore 
allophycocyanin (APC), and then stained with APC and NP-PE. Figure 15 
shows that all CD19-APC cells are NP and almost all B220- NP cells are 
APC . Therefore, we can be confident that CD19-NP cells in QM mice 
correspond to CD19- antigen binding cells in APC and PE immunised mice. 
Bone marrow cells and splenocytes from QM mice were also used in some 
preliminary experiments to investigate the function of the antigen capturing 
cells. For example, a well-documented feature of antigen presenting cells, 
such as dendritic cells, is the rapid up-regulation of MHC class II upon 
maturation [164]. LPS is a potent stimulator of DC maturation and has been 
shown to trigger maturation, including up-regulation of MHC class II, within 
48 hours. We looked to see if the antigen capturing cells, which express low 
to intermediate levels of MHC class II, showed signs of maturation following 
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Figure 14 Macropinocytosis Assay 
Bone marrow derived DC 
(A) FITC-dextran uptake by positive control immature DC. A heterogeneous 
DC population (40% dendritic morphology) was obtained from bone marrow. Cells 
were incubated with FITC-dextran at 0 or 37°C. At various time points cells were 
removed and washed with ice cold PBS-azide to prevent further uptake. Cells were 
stained with anti-MHC class II biotin/streptavidin PE analysed by FACS. Dead cells 
were excluded with 7AAD. Plots show the level of FITC-dextran uptake by gated 
MHC class II + cells over 1 hour, numbers indicate length of FITC-dextran incubation 
in minutes.(B) Whole splenocytes from a mouse 8 weeks after PE immunisation 
were incubated with FITC-dextran, as above. Incubated cells were washed and 
stained with PE before FACS analysis. Dead cells were excluded with 7AAD. Plots 
show the level of FITC fluorescence on gated PE cells. Note DCs in (A) and PE 
cells in (B) have different levels of autoflouresence so direct comparison cannot be 
made. This experiment was repeated using bone marrow PE cells from another 
mouse and similar results were obtained. 
We stimulated whole bone marrow cells from QM mice with LPS and found 
that while B220- NP cells could still be detected after 48 hours, they had not 
upregulated MHC class II (Figure 16) Nor had expression of CD11c altered 
(not shown). For reasons that are not clear B220- NP cells from QM mice 
seem to generally express slightly higher levels of MHC class II (ex vivo) than 
B220- PE cells from PE immunised mice. One limitation of this experiment is 
that B220Id B cells are likely to differentiate to B220-/ low  Id plasma cells in 
culture with LPS and will be mistaken for the antigen capturing cells. One 
way around this would be to deplete CD19 cells before culture. It is also 
possible that B220- antigen capturing cells will down regulate Fc1R1, or the 
IgG will dissociate from them in culture. In this case they would no longer be 
identifiable. The only way around these problems would be to pre-sort B220-
NP cells by FAGS. However in doing so it is likely that FcyRl will be cross-
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QM mice were immunised and boosted with APC. 2 weeks later spleen and 
bone marrow were harvested and analysed by 3 colour flow cytometry for 
CD19 expression, NP binding and APC binding. In each plot CD19 is on the 
x-axis. CD19-NP (R2) are back gated to show their APC binding activity and 
CD19-APC cells are back-gated to show their NP binding activity. A, spleen; 
B, bone marrow. Data shown is from one mouse and is representative of 
three mice analysed. 
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We have shown that FcR y  chain -I- mice lack B220- antigen capturing 
cells. The simplest explanation for this is that the Ig on the surface of these 
cells is bound directly by a FcR containing the FcR ' chain. We have excluded 
a role for the low affinity FcyRIII, therefore, it must be either the high affinity 
Ig receptors FcyRl and possibily also FcR1, which are involved. The FcR y 
chain is reported to be restricted to myeloid cells and it has not been found 
on T or B cells [148]. However, the absence of the FcR y chain causes 
pleiotropic immune defects, including inefficient clearance of immune 
complexes [166]. Immune complexes are known to regulate B cell responses 
both positively and negatively and so it is possible that a qualitative or 
quantitative deficiency in anti-PE antibody production in these mice is 
responsible for the failure to detect B220- PE cells. One group has reported 
that the affinity maturation of B cell responses and the magnitude of primary 
and secondary antibody responses in FcR y chain -I- mice are normal [147]. 
However, a more recent study found that FcR y chain -I- mice have 
approximately two fold lower levels of specific antibody across all IgG 
subclasses, 2 weeks after primary challenge [148]. This defect is more 
pronounced at lower doses of antigen and so the discrepancy between this 
and the older study may be due to differences in the immunisation 
procedures. We observe normal numbers of B220PE cells in these mice, 
suggesting the anti-PE B cell responses are unaffected. This was confirmed 
on later examination of primary anti-PE serum antibody responses (see 
chapter 4), which are normal in FcR y -I- mice. 
On the basis of our earlier observations we suspected that the antigen 
binding activity of B220 PE cells was conferred by surface bound 
monomeric IgG. In agreement with this, FcyRl can bind monomeric 1g. The 
rapid rate of BrdU incorporation by these cells tells us that this is a rapidly 
replenished population and therefore, unlike long-lived FDC, the Ig on their 
surface must have been acquired recently. Given that the antibodies in the 
serum have a half-life of only a few days [133], the long-lived presence of 
B220- PE cells must be due to prolonged production of anti-PE Ig by long 
lived plasma cells. Interestingly, the two tissues where we find the antigen 
capturing cells, the spleen and bone marrow, are the two sites where long-
lived plasma cells are found [108], [109]. Which means these antigen-
capturing cells are ideally situated to pick up and concentrate Ig on their 
surface. 
Although B220- PE cells are dividing rapidly (50% BrdU in 4 days) 6 
months after immunisation, their turnover is even faster in the earlier phase 
of the response. This may be in response to factors such as antigen or 
cytokines, which are plentiful immediately after immunisation but gradually 
diminish over time. If antigen influences the rate of turnover of B220 - PE 
cells then we would expect B220- PE cells to turn over more rapidly in the 
spleen, where antigen is trapped for long periods on FDC, than in the bone 
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marrow where antigen is not retained [127]. The present data suggests this 
may be the case as the high level of turnover is maintained (for up to 12 
weeks) in the spleen, but not in the bone marrow. 
Although we have identified FcyRl as the mechanism by which B220-
PE cells capture antigen, it is not clear what their function may be. As B220-
PE cells bind IgG but not 1gM they can only capture the immunising antigen 
late in the primary response or in the secondary response, when IgG is 
produced. A variety of functions have been attributed to FcyRl and FccRl, 
which must all be considered possible functions of B220- antigen capturing 
cells. These fall into two broad categories - effector functions or 
immunoregulatory functions. FcyRl is expressed by macrophages, 
monocytes and dendritic cells, and can be upregulated by IFN-y [162]. This 
inflammatory cytokine can also induce de novo expression of FcyRl on 
neutrophils and eosinophils. FcyRI effector functions include phagocytosis of 
IgG-opsonised particles and triggering of cytotoxic activity against IgG 
coated targets - antibody dependent cell cytotoxicity(ADCC). FcyRl may also 
have an important role in regulating adaptive immune responses, as antigen 
targeted to this receptor is processed and presented on MHC class I and 
MHC class II by dendritic cells in vitro, [167], [168]. However, a physiological 
role for FcyRl in promoting normal adaptive immune responses in vivo has 
not been demonstrated. 
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FccRl is predominantly expressed by mast cells. Resting mast cells are coated 
with monomeric serum IgE bound with high affinity by this receptor. Cross-
linking of FcER1 by antigen causes degranulation and release of 
inflammatory mediators. Basophils are thought to be the re-circulating 
counterparts of mast cells and, interestingly, one flow cytometry study of 
allergen specific cells found in human blood describes a population of 
IgECD19-  allergen binding cells which are basophilic granulocytes [169]. 
These cells sound vaguely similar to the CD19-PE cells. However, unlike 
these human CD19- antigen -binding cells, our B220 PE cells are not 
basophilic. Moreover, they do not resemble basophils in their nuclear 
morphology. In fact, B220- PE cells in the bone marrow do not physically 
resemble any of the innate effector cells that use FccRl or FcyRl. Rather, their 
CD40, MHC class II low/ intermediate phenotype is suggestive of an 
antigen presenting function, rather than an effector cell function. The - CD4 
CD8, CDllclow, CD11b'", DEC-205 -, non-adherent - profile of these cells 
does not directly match any of the three splenic mouse DC populations 
described by Shortman and co-workers [170]. 
CD4, CD8-, CDllbwgh, DEC2051ow 
CD4-, CD8-, CD11bhigh, DEC2051o%' (myeloid DC) 
CD4-, CD8, Cdllblow, 	 (lymphoid DC) 
It is possible that the B220- antigen capturing cells are DC precursors, 
although in preliminary in vitro experiments they did not display hallmark 
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immature DC activities such as macropinocytosis and maturation in 
response to LPS. However, the definitive test for APC function would be to 
purify these B220- antigen capturing cells and assess their ability to stimulate 
naïve and memory T cells, either in vitro or in vivo, in comparison to a 
conventional APC subset. 
The potent effects of secreted Ig on the induction and regulation of adaptive 
T and B cell responses are well documented, but the mechanisms are ill 
defined. This means there are many potential roles for an antigen- capturing 
cell, which may present antigen to T cells, and which resides in the spleen 
and bone marrow. Four of these possibilities: (A) down-regulation of 
inflammatory T/ B cell responses; (B) initiation of secondary T cell responses; 
(3) presentation of FDC antigen depots to T cells; (4) enhancement of plasma 
cell survival, are discussed below and illustrated in Figure 17 
Figure 17A. FcgRl does not bind all IgG subclasses with equivalent affinity, 
in mouse the hierarchy (in the monomeric form) is 
IgG2a>>IgGl>IgG2bIgG3 [171]. Given this preference for IgG2a, B220- PE 
cells may be specifically involved in regulating responses in which this 
isotype is produced. In the murine system IgG2a is regarded as the most 
inflammatory IgG isotype due to the propensity of its Fc domain to fix 
complement and interact with Fc receptors on cytotoxic effector cells. Isotype 
switching to IgG2a is promoted by the Thi cytokine IFN-y and IgG2a 
production is associated with Thi-type responses, for example anti-viral 
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responses. Autoantibodies of the IgG2a subclass have been shown to have 
the greatest capacity to induce experimental autoimmune disease [[1371. The 
B220- antigen capturing cells would be ideally situated as mediators of 
negative feedback control of inflammatory responses through IgG2a (Figure 
17A). There are indications that B cells may downregulate inflammatory 
responses through secreted 1g. For example, compared to wild type mice, B 
cell deficient MT mice form more vigorous hepatic granulomas in response 
to Leishmancii donovania infection, which leads to augmented tissue 
pathology. But, transfer of serum protects MT mice from this self-
destructive response [172]. Similarly, j.iMT mice suffer enhanced tissue 
pathology in the later stages of Schistosomiasis mansoni infection due to an 
uncontrolled inflammatory response 
This defect is replicated in FcR y  chain-/- mice [173]. In neither study was the 
mechanism by which Ig normally controls these damaging responses 
identified, but both groups ruled out the involvement of an overt shift in 
Thl/Th2 cytokine production. It would be interesting to test the involvement 
of the antigen capturing cell in this phenomenon by looking to see if transfer 
B220- PE cells from wild type mice has any ameliorating effect on the 
outcome of these parasite infections in FcR y -/- mice. 
94 
Figure 17 	Potential roles of antigen capturing cells 
A 	Down regulation of inflammatory T/B responses 
Y 3. -" 	 2. 
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Figure 17B. It is not known which types of antigen presenting cell are 
most important in initiating recall responses. In vitro B cells are known to be 
highly efficient at presenting the antigen which their BCR is specific for, thus 
the expanded antigen specific memory B cell clones may be important in 
restimulating memory T cells. If the antigen capturing cells have antigen 
presentation capacity then they would be expected to be very good at 
presenting those antigens for which the serum IgG on their surface is specific. 
In this way these cells could be involved in restimulating memory T cells 
(Figure 17B). As mentioned above Fc'yRl preferentially binds IgG2a so the 
B220- antigen capturing cells would be most efficient at presenting antigens 
that induced long lived IgG2a plasma cells during the primary challenge. 
Figure 17C. These cells could also be involved in maintaining T cell 
memory. Early studies showed that T cell memory declined rapidly in the 
absence of antigen, thus memory T cells were believed to require periodic 
stimulation by antigen. More recent studies, in which transgenic T cells were 
transferred into MHC class I and MHC class II deficient mice, have shown 
memory CD4 and CD8 T cells can survive in the absence of TCR tickling and 
therefore do not require antigen [174],[175]. However, real memory T cells, in 
an intact complex immune system, are under tight homeostatic control. In the 
face of competition it is likely that persistent antigen will allow the survival of 
memory T cell clones that would otherwise be squeezed out. A recent study 
found long livedCD4 T cell memory required periodic presentation of antigen 
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by DCs [152]. However, B cells were also found to be critical as they support 
the FDC environment in which antigen can be trapped for long periods. 
Figure 17 C illustrates how the B220 antigen-capturing cells could be the link 
between the native antigen trapped on FDCs (which cannot present antigen) 
and memory T cells. 
Figure 17D. Given that B220- antigen capturing cells are found in both spleen 
and bone marrow, they may be involved in regulating the long lived plasma 
cells that reside there. It is not known which factors are required to sustain 
long lived plasma cells, which do not divide and persist for at least 1 year in 
mice [109] although it has been shown that antigen is not required [110]. The 
density of plasma cells that can be maintained long term in the spleen is finite 
[176]. It has been suggested that plasma cell capacity of the spleen is 
determined by a population of CD11c 4 myeloid DC in the red pulp, which 
associate with and promote the survival of plasma cells [177]. It is possible 
that the B220- antigen capturing cells may be related to this DC population 
(Figure 17D). 
Chapter 4 Immune responses in FcR y  chain mice 
Introduction 
There are many potential functions for the B220- antigen capturing cell given 
its tissue distribution and phenotype. Its relative rarity made in vitro 
functional assessment impractical and so I chose to analyse in vivo T and B 
cell responses in the FcR y  chain knockout mouse, which lack this functional 
cell. Given the longevity of the antigen binding capacity, I focussed on long 
term and memory responses. Previously two groups had examined 
responses to model antigens in FcR y -I- mice: Vora and co workers 
concluded there was no defect in primary or secondary antibody responses 
whereas Saito's group more recently described a partial defect in early B cell 
and T cell responses [148],[147]. 
Results 
4.1 FcR y chain mice have normal long-lived plasma cells. 
FcR y -/- and C57BL/ 6 mice were immunised with PE as previously 
described. At 4 and 12 weeks after immunisation, spleen and bone marrow 
were harvested and the frequency of PE specific plasma cells in the spleen 
and bone marrow was measured by ELISPOT assay. Figure 18 shows that at 
4 weeks FcR y-I- and wild type mice had formed equivalent numbers of PE 
specific plasma cells in the spleen and bone marrow. At 12 weeks the plasma 
cells have been maintained at the same level in FcR 'y -I- and wild-type mice. 
4.2 Primary and secondary IgG responses in FcR y mice 
To test the ability of FcR y -I- mice to form acute and long lived IgG 
responses, serum levels of anti-FE IgG in FE immunised FcR y -/ and 
C57BL/6 mice were assessed over a period of 20 weeks. Figure 19 shows that 
both mice form equally good early response (3 weeks) and both maintain 
high levels of anti-FE IgG for up to 20 weeks after immunisation. After 20 
weeks these mice were given a secondary boost of PE, in the absence of 
adjuvant, to test B cell recall responses. IgG responses in both knockout and 
wild type mice were found to be equally robust (Figure 20). 
4.3FcR y chain mice have defective T cell memory. 
FE specific T cell memory in FcR ' -I- mice was assessed at 22 weeks post 
immunisation using an adoptive transfer system, outlined in Figure 21. The 
ability to provide help for primed B cells to produce antibody in response to 
a dependent antigen was used as a measure of T cell memory. Splenocytes 
from NF-KLH primed B6-IgHa mice were transferred together with graded 
doses of splenocytes from FE primed FcR y  or C57BL/6 mice into sub-
lethally irradiated hosts. 1 day after transfer the hosts were challenged with 
soluble NF-PE and 6 days later were bled, serum anti-NP IgGi (allotype-4a) 
titres were measured by ELISA. As shown in figure 22, only mice that 
received wild type T cells, (with the exception of a single mouse in the group 
that received 3 x 10 6 FcR -I- cells) formed an anti-NP IgGi response above 
background. 
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The number of wild type CD4 cells transferred does not influence the size of 
the anti-NP IgGi response, therefore, some other factor, such as the number 
of anti-NP B cell precursors or the amount of antigen must be limiting at this 
point. This initial experiment should be repeated to confirm this striking 
result. In addition, it will be important to conduct the same experiment using 
T cells taken immediately after the acute phase of the response, example 2 
weeks alter priming. At the moment we do not know if the defect we see in T 
cell memory in FcR y / mice is due to a defect in the formation of memory T 











Figure 18 PE-specific plasma cells in FcR4 spleen and bone marrow 























Frequencies of cells secreting anti-PE lgG in the spleen (A), and bone 
marrow (B) were measured by ELISPOT assay at 4 weeks and 12 weeks 
after PE immunisation. Each point represents an individual mouse. Solid 
diamonds represent wildtype C57BL6 mice, empty diamonds represent FcR 
chain " mice. A bar shows mean frequency of each group, n=6-8. The 
background frequency of PE specific AFC in unimmunised mice was zero in 
both spleen and bone marrow. 
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Figure 19 Maintenance of serum anti-PE lgG in FcR y mice 
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The relative titres of anti-PE lgG in the serum of FcR 'y " and wild type 
C57BL/6 at various times after immunisation were measured by ELISA. 
Each line in the graphs above represents an individual mouse; there were 10 
FcR y  mice (A) and 8 wildtype mice (B). There was one non responder in 
the wild-type group which has not been plotted. 
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Figure 20 Secondary anti-PE I gG responses in FcR y mice 
primed FcR y -I- primed FcR y +1+ naïve FcR y +1+ 
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FcR y ' and FcR y T animals which had been primed with PE I 5odays 
earlier(a-f), together with a cohort of unimmunised FcR g/ control animals 
(g,h), were boosted with PE. Serum levels of anti-PE lgG at day 0, 4 and 10 
after this challenge were measured by ELISA. Data is presented as the OD 
at 405 nm against serum dilution factor of each sample.There were 5 mice in 
each group. One mouse from the FcR 7/ primed group failed to respond in 






Figure 21 	Adoptive transfer strategy to assess helper T cell memory 
PE 	PE 
NP-KW 







FcR y chain ' and wild type C57BL/6 (136) mice were immunised with PE and 
22 weeks later splenocytes were harvested. At the same time, splenocytes 
were harvested from NP-KLH immunised syngeneic mice which carry the 
IgHa allotypic marker (B6-lgHa). Splenocytes from immunised FcR 	or B6 
donors were transferred together with the B6-lgHa splenocytes into 
sublethally irradiated B6 hosts. The next day hosts were challenged with 
soluble NP-PE and 6 days later serum was collected. Only those mice which 
received PE specific T cell help can form anti-NP lgGl(a-allotype) antibody 
responses. As all mice receive the same number of NP-specific B cells, the 
amount of anti-NP IgGla formed will be proportional to the amount to PE-
specific T cell help. 
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Figure 22 Helper T cell memory in FcR mice 
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WT 	 FcR-I- 
transferred CD4 T cells x1  
Irradiated B6 hosts were all given splenocytes from NP-KLH primed B6-IgHa 
mice (NP primed responder B cells) and 3 x 105 ,  106 or 3 xl 06  CD4 
splenocytes from wild type (WT) or FcR mice primed with PE 22 weeks 
earlier. A control group were given 3 x 106  splenocytes from naïve B6 mice. 
There were 5 recipient mice per group. All mice were primed with NP-PE and 
bled 6 days later. Serum anti-NP lgGla was measured by ELISA. 
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Discussion 
We have examined acute primary, long term and recall B cell responses 
to a T dependent antigen in intact FcR y -I- mice and found them to be entirely 
normal. This is in agreement with an earlier study that asked whether the 
enhanced deposition of immune complexes on FDC seen in FcR y -I- mice had 
any effect on the maturation of B cell responses [147]. However, a more recent 
study showed that litres of specific antibodies of all IgG subclasses, at 2 weeks 
after immunisation, were around 2 fold lower in FcR y -I- mice [148]. It is 
likely that differences in antigen dose, adjuvant or immunisation route 
account for these contrasting findings. In addition to ablating the B220-
antigen binding population, deletion of the FcR y  chain causes diminished 
immune complex clearance and enhanced deposition of immune complexes 
on FDC. Therefore, any subtle defect in antibody responses in FcR y -I- mice, 
caused by the absence of B220 antigen capturing cells, could easily be 
obscured by other aberrations. Perhaps we would see a defect in antibody 
responses in FcR y -I- mice using lower doses of a model antigen however, real 
replicating antigens are encountered in abundance - therefore, the B220-
antigen binding cells are unlikely to have a critical physiological role in 
regulating antibody responses. It is difficult to suggest other mouse models 
that could be used to investigate the role of B220- antigen capturing cells in B 
cell responses. Other knock out mice that lack detectable B220- antigen 
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binding cells (such as CD40-I - or MHC class II -I- mice), do so because of 
fundamental defects in B cell responses. 
The adoptive transfer experiment suggests there is a defect in long -term 
helper T cell memory in FcR T -- mice. Memory B cell responses are 
dependent on T cell help and so it is surprising that, as we have shown, FcR y 
-I- mice form normal IgG recall responses. Given this result it is likely that any 
defect in T helper cell memory in FcR y -I- mice is only partial and perhaps is 
compensated for in Ig recall responses by the enhanced persistence of antigen. 
The present study does not show if the defect is in the formation or the 
maintenance of memory T cells. A recent study described defects in early T 
cell proliferative responses in vivo, and in delayed-type hypersensitivity recall 
responses in FcR y chain -I- mice [148]. This is consistent with a model in 
which Fc receptors on APC s are required for efficient priming of the T cell 
memory pool. The authors observe the same defect in T cell priming in B cell 
deficient pMT mice. In contrast to this, a recent study by another group 
showed that p.MT and wild type mice have equivalent numbers of antigen 
specific CD4 T cell precursors at 2 weeks post immunisation, but at 12 weeks 
only wild type mice had maintained those precursor frequencies [152]. The 
conclusion of this report is that CD4 T cell maintenance is dependent on the 
presence of B cells. Interestingly, it was not direct contact with B cells 
themselves that was deemed to be critical for memory T cell survival - rather 
a factor produced by B cells. Over the years there have been many 
investigations into whether or not B cells are required for the development of 
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effective T cell responses. However the issue is still unresolved. Early 
experiments in normal mice depleted of B cells indicated CD4 T cell responses 
were reduced in the absence of B cells [178] [179] [180]. However multiple 
other studies have claimed B cells are unnecessary for normal T cell priming 
to model protein antigens, viruses and parasites. In another gene targeted B 
cell deficient model, JHD -I- mice, involvement of B cells was shown to be 
critical for CD4 T cell responses [1811. More recently, a study in j.tMT mice 
reported that B cells are required for memory T cell development but not their 
survival [182]. This contradicts directly with the findings of van Essen and co-
workers (described above) who used the same protein antigen and the same 
measure of memory - IL-2 production. Perhaps the discrepancy comes down 
to the definition of 'priming'. Linton et al. measure CD4 cell priming at day 5, 
whereas van Essen et al. measure priming at 2 weeks. In any case, I would 
suggest the question should not be - does CD4 T cell memory require B 
cells? But rather - under what conditions do B cells become important for 
CD4 T cell memory? This latter issue has important implications for vaccine 
design. 
The results of Humano et al., and those presented here, suggest that serum 
IgG through interactions with Fc receptors on myeloid cells can be critical to 
CD4 memory. Further work needs to be done in pinpointing the stage at 
which the FcR dependent mechanism is required. In addition, the cell types 
mediating this effect need to be identified. The myeloid cell described here, 
which binds antigen in an FcyRl dependent manner, may be involved. 
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Looking to see if purified B220 PE cells, when transferred into FcR y -I- mice, 
can correct the observed defect in CD4 T cell memory, would test this 
hypothesis. 
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Chapter 5: CD40 dependence of B cell memory 
Introduction 
Antibody responses to thymus-dependent (TD) antigens require 
cognate T-B cell interaction. We know CD40 is a crucial player in this 
interaction. CD40 and its ligand, CD154, form a costimulatory molecular pair 
belonging to the TNFR/TNF family, which includes many other key 
regulators of immunity. CD40 is expressed constitutively by B cells, 
macrophages, DC and some non-professional APC; whereas CD154 is 
transiently induced on T cells following activation. The role of CD40 signals 
in TD antibody responses in vivo was first demonstrated when the 
administration of anti-CD154 mAb was shown to prevent both isotype 
switching and GC formation [183]. The importance of CD40-CD154 was 
further highlighted when it was shown that X-linked Hyper-IgM syndrome 
(XHIM) in humans, which is characterised by defects in both isotype 
switching and GC formation, is due to loss-of-function mutations in CD154 
[184]. These findings were later confirmed in mice with targeted deletional 
mutations in CD40 and CD154 [91], [92]. While these mice have normal 
antibody responses to TI antigens, they cannot form GC and produce only 
1gM antibody in response to TD antigens. From these studies it is clear that 
the generation of classical, post-GC, class-switched memory B cells is 
absolutely dependent on CD40-CD154 signals. 
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However, a study from Gray and co-workers showed that the 1gM 
recall response is enhanced or at least unaffected by CD40-Ig blockade of 
CD40-CD154 signals [185]. More recent studies have challenged the accepted 
definition of a memory B cell as a class switched IgG, A or E expressing cells. 
Paramithiotis and Cooper made the initial observation that there is a 
compartment of IgD mutated B cells in humans [121]. Then, in human 
peripheral blood, CD27 was found to be expressed exclusively by B cells that 
have somatically mutated V genes - the hallmark of memory [120, 122]. 
This led to the discovery of four distinct subsets of (CD27) B memory cell in 
humans: (1)IgMIgD (switched), (2) IgM, (3) IgD and (4) 1gW IgD 
Contrary to expectations, the majority of human memory B cells are in fact 
non-switched. Unfortunately no clear surface marker of memory B cells has 
been described in the mouse. Older adoptive transfer studies have implied 
there may be an element of non-switched B cell memory in rodents [186], 
[187]. More convincingly, a recent study of hapten-specific Ig mRNA 
transcripts revealed 1gM and IgD memory responses at both the cellular and 
secretory level [123]. 
The origins and functions of non-switched memory B cells are not known. 
The signals leading to their development may well be different from 
classical, high affinity IgG memory cells. We asked the question - can B cell 
memory develop in the absence of CD40 signals? Very recently it has been 
shown that XHIM patients have a population of somatically mutated B cells, 
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indicating that there is an alternative, CD154-independent, memory B cell 
differentiation pathway in humans [124]. We investigated the issue of 
CD40/CD154 -independent memory in mice by examining primary and 
secondary B cell responses to model TD antigens in CD40 deficient mice. 
Two assays of memory were used: (1) measurement of serum antibody levels 
by ELISA and (2) quantification of hapten-specific 1gM mRNA transcripts by 
RT-PCR. 
Results 
5.1 Wild type and CD40 mice form enhanced secondary 1gM responses 
Initially we chose to assess 1gM memory responses in CD40-/- mice simply by 
measuring serum levels of antigen-specific 1gM following primary and 
secondary challenges. The TD antigen DNP-KLH has the advantage of 
inducing robust antibody responses without the need for alum-precipitation 
or a microbially derived adjuvant. This was important in the current study as 
it has been shown that certain microbially derived TI-1 antigens such as 
TNP-LPS, or TI-2 antigens when delivered with LPS, can generate memory B 
cells [66]. We did not want to alum-precipitate our antigen as this can lead to 
large artificial antigen deposits, which could cause chronic stimulation of 
antigen-specific B cells and so give a false impression of memory. Therefore, 
by delivering a primary dose of soluble DNP-KLH i.p., followed by a 
secondary identical dose 12 weeks later, we tested for CD40-independent 
memory in a highly stringent manner. 
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CD40-/ -  and wild type C57BL/6 mice were both found to produce a primary 
anti-DNP 1gM response, of comparable magnitude, which peaks at day 4. 
(Figure 23A, B). The secondary response, 12 weeks after the priming dose, 
has similar kinetics, but is on average 5-10 fold greater in magnitude in both 
wild type and CD40 -/ - animals. Interestingly, there also seems to be 
maintenance of anti-DNP 1gM serum levels 12 weeks after primary 
immunisation, in CD40/ and wild type mice. This finding was unexpected, 
although a recent study of B cell responses to a TI-2 antigen, NP-Ficoll, [177 
which found antigen-specific splenic plasma blasts were still present at 20% 
of their peak numbers, 3 months after immunisation. This indicates that 
long-lived antibody responses are not critically dependent on T cell help. We 
noticed a great deal of variability in the background levels of anti-DNP 1gM 
in unimmunised mice, with some individuals having fairly high levels. This 
may be an indication that there is cross-reactivity between DNP and a 
ubiquitous environmental antigen, in other words the B cells responding to 
DNP in the primary response may not be truly naive. This would also 
account for the high level of variability that we see in magnitude of anti-DNP 
1gM responses. 
Although the secondary anti-DNP 1gM response is enhanced in size relative 
to the primary response in both wild type and CD40/ mice, no improvement 
is seen in the kinetics of the response. In both primary and secondary 
challenges the peak of the response is day 4. Also, the quantitative 
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enhancement is relatively small compared to that seen in the anti-DNP IgGi 
secondary response. Overall the secondary 1gM response to DNP-KLH in 
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CD40' mice (back crossed 7 generations to C57BL/6) or C57BL/6 mice that 
were unimmunised or had been primed 12 weeks previously with DNP-KLH, 
were challenged with DNP-KLH. All mice were bled at 0,2,4,7, and 11 days 
after this primary or secondary challenge. Serum levels of anti-DNP and anti-
KLH 1gM were measured by ELISA. In A-D above the response of each 
individual mouse over the 11 day period is represented by a single line. Left 
hand graphs show primary and secondary responses in CD40' groups, right 
hand graphs show responses in C57BL/6 groups. A and B show anti-DNP 
responses, C and D show anti-KLH responses, in the same group of mice. In 
each sub-group there were 5-6 mice (n5-6), however there was one non-
responder in the CD40' secondary response group, which has been omitted. 
116 
humoral memory response. To confuse the picture further, anti-DNP 1gM 
responses do not mirror anti-KLH 1gM responses in the same mice (Figure 23 
C, D). While both CD40-/- and C57BL6 mice appear to have improved 
secondary anti-KLH responses, the secondary response in C57BL6 mice is 
around 10 fold greater than in the CD40-/- mice. Furthermore, anti-KLH 1gM 
levels are maintained in wild-type mice but not in CD40-/- mice. That two 
antigens should elicit such different 1gM responses might be because 
functionally distinct IgM B cell compartments have distinct repertoires. Bi 
and MZ B cells have generally poly-reactive BCRs and secrete Ig rapidly on 
activation [188]. The relatively high levels of 'natural antibody' which cross-
reacts with DNP but not KLH suggest that B cell clones that cross-react with 
DNP have been pre-selected into the Bi and/or MZ B cell compartments. 
This would explain the equally rapid primary and secondary responses to 
DNP. On the other hand, follicular (FO) B cells take longer to differentiate 
into effectors, and seem to predominate in responses to protein epitopes due 
U 11 their highly diverse repertoire, suggesting the delayed primary 1gM 
response to KLH may be mediated by FO B cells. 
5.2 Carrier priming effect in 1gM recall responses. 
There are two explanations for the enhanced secondary anti-DNP 1gM 
response seen in both CD40-/- and WT mice. Either there is an increase in the 
frequency of DNP-specific B cell precursors following primary immunisation 
that is long lived, i.e. it is a memory B cell phenomenon. Or there is an 
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Figure 24 1gM responses in CD40 4 mice - carrier priming 
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The contribution of carrier primed T cells to secondary anti-DNP 1gM 
response in CD40 and wild-type mice was assessed by challenging mice 
which had been immunised with either DNP-KLH or KLH only 12 weeks 
previously with DNP-KLH. At dO, d2, d4, d7 and dl  mice were bled and 
serum levels of anti-DNP 1gM were measured by ELISA. (A) shows the 
effects of carrier priming in CD40 1 , (B) shows the effect of carrier priming in 








increase in the frequency of KLH-specific helper I cells i.e. it is a memory T 
cell phenomenon. Although this response is CD40-independent, it may still 
be promoted by antigen-specific T cells through other costimulatory 
molecules or cytokines. 
In the past, experiments which compared hapten-specific B cell responses in 
carrier-hapten and carrier-only primed mice have attributed enhanced 
secondary 1gM responses to wholly to increases in carrier-specific helper T 
cell frequency [68],[33]. However, the study by White [123], found secondary 
1gM responses to be independent of carrier-primed T cells. To resolve this 
issue in the case of CD40-/- secondary responses, we compared anti-DNP 
1gM responses in CD40-I- and wild type mice, which had been primed with 
either DNP-KLH or KLH alone (carrier primed). Figure 24 shows that in both 
CD40-/- and wild type groups the anti-DNP 1gM responses of DNP-KLH-
primed mice are, on average, higher than in KLH-only primed mice. But this 
difference is only marginal. Thus, an element of the enhanced secondary 
anti-DNP response in DNP-KLH primed mice, as measured by ELISA, can 
possibly be attributed to DNP-specific memory B cells. However the innate 
variability of serum anti-DNP 1gM titres make it difficult to obtain 
statistically significant proof in this system. 
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5.3 Limitations of EL ISA -based 1gM assays 
One thing that can be taken from these experiments is just how critical 
the choice of antigen is when assessing 1gM B cell memory. The nature of the 
antigen may skew results in unpredictable ways most probably due to the 
compartmentalisation of repertoire and function in the B cell system. In 
addition, I think these experiments highlight the unsuitability of traditional 
affinity-based methods in assessing non-switched B cell memory. Recently, a 
more appropriate antigen and isotype-specific, RT-PCR based method of 
assessing B-cell memory in mice has been described [123]. This technique, 
based on TCR spectratyping methods [189], is highly sensitive and has the 
advantage of not being affinity-biased - i.e. lower affinity clones have a 
chance to show themselves. In addition, both secreted and membrane forms 
of any isotype can be quantified. This technique demonstrated the existence 
of 1gM memory responses in normal mice and we decided that this would be 
the best method of assessing 1gM memory in CD40+ mice 
5.4 Measuring specific B cell responses by RT-PCR 
Early studies of affinity maturation have shown that the high-affinity B cell 
response to the hapten phenyl-oxazolone,(PhOx), in BALB/c mice is 
dominated by clones that express the ViiOX-1 gene and have a short CDR3 of 
6 amino acids, conforming to the general motif DXG)(XW [190, 191]. Ox-
specific VHOX-1 expression can be detected by isotype-specific PCR, as 
illustrated in Figure 25. Due to the random process of VDJ recombination, 
CDR3 varies in length from 3-18 amino acids. In an unselected B cell 
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population there is a normal distribution of V-10X-1 CDR3 lengths with a 
modal value of 10. As a result RT-PCR products spanning the CDR3 vary in 
length by single codon units. These PCR products can be resolved by 
polyacrylamide gel electrophoresis (PAGE). In the case of VHOX-1, PhOx-
specific clonal expansion can be clearly visualised as an over-representation 
of the band corresponding to a 6-amino acid long CDR3 (called the C6 band 
hereafter). The C6 band can be cut out, cloned and sequenced to confirm the 
presence of the DXGXXW Ox-motif. The intensity of the C6 band relative to 
the whole VHOX-1 ladder, combined with the frequency of the Ox-motif, can 
be used as a measure of PhOx-specific B cell clonal expansion or antibody 
secretion in any lymphoid tissue. In this study mRNA from whole spleen 
was used. 
5.5 VH-OX-1 1gM memory responses in CD40' mice. 
CD40-/- mice on the BALB/c background were obtained for the 
purposes of this study as C57BL/6 mice have a deletion in the Q52 VH gene 
family that incorporates VHOX-1. Whole spleen mRNA was obtained from 
BALB/c or CD40-/- mice which were: (a) unimmunised; (b) GSA-Ox primed 
plus 11 days; (c) GSA-Ox primed plus 87 days; (d) GSA-Ox primed plus 83 
days then GSA-Ox boosted plus 4 days. To control for the effects of carrier 
primed T cells on 1gM responses, a group of GSA primed plus 83 days, then 
GSA-Ox boosted plus 4 days, BALB/c mice were included. In each case the 
priming dose was 100tg alum-precipitated antigen plus pertussis, injected 
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Outline of the general scheme for Ig RT-PCR, taken from White and Gray, 
2000. The positions of VH specific and isotype specific primers used in initial 
and run-off PCR are shown relative to the lg heavy chain cDNA. The 
autoradiograph images show typical ladders, representative of repertoires of 
different complexity, which were obtained in their study; (a) memlgD 
unimmunized mouse; (b) seclgM phOx-boosted mouse; (c) seclgGi phOx-
primed mouse; (d) secigGi phOx-boosted mouse. The position of the band 
which corresponds to the 6 amino acid long Ox motif CDR3 (C6) is indicated 
by the arrow. The presence of the Ox motif can be confirmed by cutting out 
the C6 band, cloning and sequencing colonies. 
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i.p.; the boost dose was 100.ig of soluble antigen, i.p.. There were 3 mice in 
each group. The molecular analysis (outlined in figure 25) was carried out 
with the supervision and assistance of Dr Harry White, Institute of Child 
Health, University College of London. Secretory j.t (sec ) and membrane .t 
(mem p.) specific VHOX-1 RT-PCR was carried out on each sample and the 
products were resolved by PAGE. Looking first at secretory 1gM (secp.), the 
C6 band is visibly enhanced in primed (P), long-term primed (L) and boosted 
(B) wild-type mice (Figure 26). Although the relative level of C6 
enhancement, particularly for the boosted mice, seems less marked than that 
previously shown [1231. In contrast, in the CD40-/- primed (P) group only 
one mouse appears to have a C6 expansion and no expansion is seen in the 
CD40-/- long-term primed (L) group. Moreover, in the CD40/ boosted (B) 
group only one mouse has a C6 expansion. As massive amounts of Ig can be 
secreted by just a few plasma cells, the sec p. data does not necessarily reflect 
clonal expansions. On the other hand the amount of membrane bound Ig that 
is produced by individual cells cannot vary by much. Therefore, mem p. data 
can give an indication of what is happening at the cellular level. In contrast 
to the sec p. ladders, the mem [t ladders are smooth indicating this is a largely 
unselected pool. 
There appears to be mem p. C6 expansions in 2/3 primed wild type 
mice and in 2/3 boosted mice wild type. However, there are no expansions 
in the corresponding CD40+ groups. It is interesting to note that in the 
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Figure 26 PAGE of VHOX-1 Ig RT-PCR product run-off 
A secretory 1gM 
	
BALBIc 	 CD40-/- 
Ci' 	C 	P 	B 	 C 	 C 	P 	C 	B 
- 	 - 
- 	 * 
C6 •..- 	 -- - 	 4 p. 	 4 
B membrane 1gM 
BALB/c 	 CD40-I- 
Ci' 	C 	P 	L 	 B 	 C 	P 	C 	B 
C6  
Phosphor-image of splenic secretory and membrane 1gM VHOX-1 Ig PCR 
products fully resolved by PAGE. Experimental groups, each of 3 mice, are 
labelled at the top in red text. OF, carrier primed + boost. C, control 
(unimmunised). F, primed (d1 1). L, long term primed (d87). B, boosted (d4). 
Arrows indicate positions of VHOx-1 transcripts with six—amino acid CDR3s. 
The secretory 1gM (A) and membrane 1gM (B) data are from the same group 
of mice. The ladders for each mouse are in the same relative position in the 
gel, with the exception that for BALB/c sec 1gM the order of groups in the gel 
is CP-C-P-B-L, but for mem 1gM it is CP-C-P-L-B. 
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carrier primed mice there is a small upregulation of C6 in sec i. but no 
corresponding upregulation in mem .t. To obtain an accurate measure of Ox-
specific expansions, phosphor-imaging software was used to measure, for 
each triplet of mice, the average density of the C6 band 'rung' relative to the 
entire ladder (Table 2). 
Table 2 	Intensity of C6 band as percentage of VHOX-1 ladder 
secretory 1u Membrane 1u 
1 	- 1 
Unimmunised control C 14.9 3.6 2.7 2.8 
prime 	lid P 8.4 4.9 5.7 2.8 
prime + 87d L 7.0 3.6 1 2.6 2.6 
t prime + 83d + boost 4d B 9.5 3.7 5.4 3.0 
carrier prime + boost + 4d CP 6.1 2.7 
The average intensity of the whole PAGE ladder and the average density of 
the C6 band, of each triplet (see Figure 26), were measured using a Fuji 
Phosphorlmager. The density of the C6 band is expressed here as a 
percentage of the whole ladder. T is BALB/c, " is CD40 . 
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As reported previously, in wild-type mice the C6 sec pt and mem p. 
transcripts are upregulated in the primary (F) and secondary (B) responses. 
In the CD40-/- there is a slight C6 upregulation during the primary sec p. 
response, but not during the secondary response. 
Taken on their own, these results suggest that CD40-/- mice make reduced 
VHOX-1 restricted, primary 1gM PhOx responses and no memory response. 
However, the C6 transcript bands must be sequenced to confirm the presence 
of the DXGXXW Ox motif. The C6 sec p. bands of each triplet were pooled, 
cloned and individual colonies were sequenced. The CDR3 amino acid 
sequences from each group are shown in Figure 27. Disappointingly, there 
appears to be no use of the Ox motif in CD40/- primed or boosted mice. The 
most obvious explanation for this is that CD40 signals are required for the 
selection and immunodominance of DXGXXW clones. Unfortunately this 
means the Ig RT-PCR method cannot be used to assess 1gM memory in 
CD40-/- mice, unless a model antigen can be found where the same VH motifs 
dominate CD40/ and CD40-/ - early responses. 
Ox-motifs are found in wild-type primed and boosted mice although at a 
much lower frequency than previously described [123]. Moreover, the clones 
that did contain the Ox motif did not harbour any somatic mutations in their 
FR3 regions (not shown). It is not clear why the Ox responses in this 
experiment were so poor. Antigen dose is one factor that might account for 
this difference. We used 100p.g of CSA-Ox, compared to 30p.g in the original 
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Figure 27 VHOX-1 CDR3 sequences 
BALBIc 
C 	 P 	 B 
WGFAYW DGGAYW DGGLLW 
YYGAYW DGGAYW DGGAYW 
DGFAYW DGFAYW TGFDYW 
WGFAYW NAMDYW DYGDYW 
DGFAYW GNYDYW DGGDYW 
WGFAYW GNYDYW DGFAYW 
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The pooled sec t C6 bands from each triplet (see Figure 26) were cloned and individual 
colonies were sequenced. The amino acid sequences of the CDR3 regions were determined. 
C, unimmunised control. P, primed dl 1. B, primed then boosted d4. CP, carrier primed then 
boosted d4. DXGXXW ox-motifs are shown in bold red. The frequency of ox-motifs is shown 
at the bottom of the columns. 
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V-1OX-1 Ig RT-PCR study. It has been reported that affinity maturation of 
PhOx responses can be influenced by the antigen dose [192]. However, in an 
antigen dose response experiment we found no difference in the size of the 
sec p. C6 transcript band at day 11, between mice primed with 5, 50 or 250 jig 
of CSA-Ox (data not shown). A more mundane explanation would be that the 
GSA-Ox we used had a lower Ox:CSA haptenation ratio leading to less 
efficient priming.If we multiply the frequency of Ox motifs in WT groups by 
the average percentage intensity of the C6 band then we can get a relative 
measure of the sec p. PhOx response in the wild type primed and boosted 
mice. So for primed mice (P) 0.11 x 8.4 = 0.92; boosted mice (B) 0.29 x 9.5 = 2.8 
and in carrier-primed boosted mice (CP) 0.25 x 6.1 = 1.5. Thus, secreted 1gM 
boost response is 3 fold greater than the primary response, and while there is 
a real carrier priming effect on the sec p. PhOx response, this does not account 
for the entire secondary response. 
Discussion 
We have not been able to obtain unambiguous data supporting the existence 
of a CD40-independent B cell memory pathway in mice - although we cannot 
rule it out either. Our data does suggest there may be an element of 
enhancement of the CD40-independent secondary 1gM response which is due 
to specific B cell clonal expansion and persistence; and we believe this is 
worth following up. 
The existence of an alternative memory B cell differentiation pathway, which 
is CD40-independent, is supported by recent studies of individuals with X- 
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linked hyper-IgM (XHIM) [124]. This syndrome is the result of mutations in 
the CD154 gene that cause complete loss of expression or signalling function. 
Like CD40 and CD154-deficient mice, these individuals do not form GCs and 
do not isotype switch. While they do not have IgM-IgD-CD27 class switched 
memory cells or IgMIgD-CD27 memory B cells, they do harbour a subset of 
CD27 B cells that are 1gW IgD [193]. The proportion of CD27IgMIgD 
cells is lower in XHIM patients than normal control individuals and at the 
time it was speculated that, given the absence of GCs in XHIM, these could 
not be bone-fide memory cells. However, a more recent study has shown that 
IgD 1gW CD27 B cells are somatically mutated to an equivalent degree in 
normal and XHIM individuals [1241). It is a remote possibility that these 
mutations arise during ontogeny as a means of diversifying the pre-immune 
repertoire, as seen in the sheep and rabbit immune systems [194]. However, 
the explanation favoured by the authors is that there are two distinct 
pathways leading to somatic hypermutation and memory cell formation: (1) a 
CD40-dependent pathway giving rise to IgM,G or A single positive memory 
cells and (2) a CD40-independent pathway generating IgDIgM memory 
cells. However it is not known what the functions of either subset are. 
We set out to establish whether there was a CD40-independent B cell memory 
pathway in mice. However, both methods that were chosen to assess non-
switched memory proved to have limitations in this study. In the report by 
White and Gray [123], the up-regulation of Ox-specific sec 1gM, at the mRNA 
level, on secondary challenge was found to be equivalent to that seen for sec 
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IgGi. However, this up-regulation cannot be seen at the level of polyclonal 
serum 1gM. We and others have found that serum levels of antigen-specific 
1gM, as measured by ELISA, are not dramatically increased on secondary 
challenge and titres are highly variable between animals [92]. In addition 
there is a high level of cross-reactive natural 1gM antibody that may be 
obscuring actual antigen-specific responses. There is some evidence to 
suggest that in mice the 1gM memory compartment is clonally distinct from 
the class-switched memory compartments and may be less mutated [123]. 
This suggests the criteria for selection into the IgM and class-switched 
memory compartments are different. Thus 1gM memory B cells may generally 
be of lower affinity or more cross-reactive. For all of these reasons, 
conventional affinity-based techniques for measuring memory - such as 
serum antibody ELISA and antigen binding by individual cells - will not be 
appropriate for assessing 1gM memory. 
Given the limitations of a protein-based 1gM memory assay, we decided to 
use a PhOx-specific Ig RT-PCR based method, which is not affinity biased, to 
assess CD40-independent memory. It was a surprise when the particular 
PhOX specific VHOX-1 /DXGXXW CDR3 motif, which has been shown in 
hybridoma studies to predominate the early response to PhOX [190, 191] did 
not also emerge in the repertoire of PhOX immunised CD40/ mice. This tells 
us that CD40-CD40L interactions can play a key role in selecting the early Ig 
repertoire of a response, independent of somatic hypermutation. It may be 
that CD40 somehow influences the selection of the pre-immune repertoire. Or 
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perhaps those high affinity B cells in the pre-immune repertoire, which are 
highly efficient at internalising and presenting antigen to T cells, only have a 
selective advantage and undergo clonal expansion when they can receive the 
mitogenic CD40 signal. In this respect, it would be interesting to know if in 
wild type mice the predominant clones early in the response, i.e. before the 
onset on somatic hypermutation, are of higher or lower affinity than those in 
CD40/- mice. 
A successful strategy for examining the CD40-dependence of 1gM memory 
will have to take into consideration the innate cross-reactivity and functional 
heterogeneity of 1gW B cell compartments. As we have shown, in the same 
non-intentionally immunised mice, different TD antigens (DNP versus KLH) 
can elicit kinetically dissimilar 1gM serum responses. It has been shown that 
transitional B cells are differentially selected into mature B cell compartments 
on the basis of BCR specificity. B cells with poly-reactive BCRs are selected 
into the static MZ and Bi pools, whereas those with low cross-reactivity are 
selected into the major, recirculating, follicular B cell compartment [49]. MZ 
and Bi cells have an activated phenotype and differentiate to 1gM secreting 
effectors much more rapidly and efficiently than follicular B cells [45, 188]. In 
the past MZ B cells and FO B cells were regarded as naïve B cells of separate 
lineage. Now it seems most probable that MZ B cells are derived from a small 
population of FO B cells. Although MZ and Bi B cells have an elevated 
activation status and are thought to be ligand selected on the basis of their 
BCR specificity [195], they are not considered to be memory cells. This 
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assumption seems to prevail largely because they develop in germ-free mice 
and rats [48]. For this reason they have been termed natural immune memory 
[49]. However, both FO and MZ B cells compartments appear to contain true 
1gM memory cells. In humans the majority of splenic MZ B cells express CD27 
and are somatically mutated[196] [197]. In rats 20% of MZ B cells, the majority 
of which are IgM, are somatically mutated [195]. The difference in MZ 
composition between laboratory rodents and humans may be a reflection of 
the differences in life span and/or pathogen exposure. As further evidence, in 
mice 1gM memory has been found to reside in both 1gM bright, IgD dull (MZ) 
B cells and 1gM dull, IgD bright (FO) B cells (H. White, personal 
communication). 
If there is an alternative, CD40 independent, memory pathway then one 
might expect to see evidence of it in responses to TI antigens. Early studies 
concluded that only TD antigen could induce memory B cells [198], and that 
is the consensus today. However, over the years there have been some reports 
of memory. B cell formation in response to TI antigens). An adoptive transfer 
study concluded that TI-2 antigens induce long-lived 1gM and IgG memory, 
but only in the presence of T cells [64]. But in contrast, Lane and co-workers 
showed that a TI-1 antigen, TNP-LPS , but not a TI-2 antigen, DNP-HES, can 
give rise to a memory B cell population [66]. 
It is not known what the function of a non-switched, possibly lower 
affinity, memory B cell pool (CD40 dependent or not) might be. Classical high 
affinity, IgG memory cells produce highly efficient, highly specialised and 
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very specific, secondary Ig responses. They are critical for immunity to most 
acute systemic viral infections. Almost all effective vaccine strategies work by 
inducing long-lived high affinity IgG responses. This would appear to be the 
best defensive strategy if pathogens only came in one variety. However many 
pathogens, the obvious example being influenza virus, exist in a range subtly 
different antigenic flavours. Also, in the case of parasites and chronic viral 
infections there is strong selective pressure for antigenic change during the 
course of the infection. Thus in the primary response it may prudent to lay 
down a population of memory B cells which have less specialised and more 
poly reactive antigen-binding sites. Although these cells may have lower 
affinity for the original antigen they will have a greater chance of recognising 
and adapting to antigenic shifts. 
1gM memory B cells may also be of advantage because in later stages of 
chronic infections and in subsequent encounters the microbe may invade a 
different anatomical location. The different switched Ig isotypes: IgGi, IgG2a, 
IgG2b, IgG3, IgE and IgA have distinct functions and anatomical 
distributions. Due to the order of constant region genes in the Ig heavy chain 
locus, an IgM or IgD cell can switch to any of these isotypes but in the 
process of switching the intervening constant regions are excised. Thus class-
switched memory cells have reduced or no functional adaptability. 
But why would a CD40 independent B cell memory pathway be 
advantageous? MZ B cells develop in CD154-/ and MHC class II -I- mice and 
their primary function is thought to be rapid secretion of 1gM in response to 
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TI-1 antigens such as bacterial polysaccharides. As I have discussed, it is 
thought that these cells are selected, possibly from FO B cells, by self-ligand 
cross-reactivity, and so this is generally thought of as a non-adaptive innate 
response. But it would seem to make sense for the repertoire of MZ B cells to 
be honed to recognition of TI antigens by experience. Perhaps this is the role 
of CD40-independent B cell memory. As I have mentioned, a significant 
proportion of MZ B cells are mutated, indicating this population does adapt 
to antigen experience. Like MZ B cells, CD27 B cells in XHIM patients secrete 
large amounts of 1gM in vitro [193]. A final interesting piece of anecdotal 
evidence comes from the work of Weller and co-workers, who found the 
XHIM patient that had the most marked expansion of IgMIgDCD27 cells 
did not present with the bacterial infections typical of XHIM [124]. 
In light of this study and others, it seems the best way to address the 
question of CD40-dependence of B cell memory in mice would be to make use 
of B cells from BCR transgenic or knock in mice. B cells from different BCR 
transgenic mice are known to preferentially develop as Bi, MZ or FO B cells 
according to their BCR specificity and density. This would allow us to 
examine 1gM memory in the different B cell sub-populations and also get 
around the problems of affinity-bias, and distinct clonal selection in CD40+ 
versus wild type mice. Chimeric mice containing detectable numbers of 
transgenic B cells could be immunised in the presence of blocking anti-CD154 
antibody. The fate of the IgM transgenic B cells in the memory phase, and 
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during secondary responses could be assessed, using the anti-idiotype 
antibody to detect them. 
Conclusions 
We aimed to further characterise the cellular basis of B cell memory. Antigen 
binding activity was used to identify cells that bind antigen in the memory 
phase of the response. A novel antigen binding compartment, which lacks B 
cell markers was identified. This is not a memory B cell or FDC population 
but most probably of DC or monocytic lineage. This finding calls into 
question recent reports of a novel B220- memory B cell compartment [116], 
[117] which on examination is found to closely resemble the myeloid antigen 
binding cell population described here. We have found no evidence of a B220-
compartment in our own studies or those of others. The only B-lineage 
surface marker we have found these cells to express is IgG. However, serum 
transfer experiments show that these cells pick up secreted 1g. Co-
immunisation with two distinct antigens showed that these B220- antigen 
binding cells can in fact bind whichever antigens the animal has been 
immunised with, presumably if a large enough IgG response is elicited. 
Previously only two antigen-binding compartments - memory B cells and 
FDCs have been described in the quiescent phase of immune responses. The 
myeloid antigen capturing cells (ACC) are clearly distinct from FDC on the 
basis of their phenotype and localisation in the bone marrow, although it 
remains possible that they are FDC precursors. There are also functional 
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differences; while FDC are very long-lived non-dividing cells that bind 
antigen in the form of immune complexes for long periods of time, ACC are 
rapidly dividing cells that bind monomeric IgG which must have been 
recently produced. ACC are detected in the spleen, bone marrow and 
peripheral blood. FDC by virtue of their antigen capturing potential are 
proposed to be involved in the generation and maintenance of memory 
responses, ACC may also be important in immune regulation. 
Immunisations of various Fc receptor and complement deficient mice have 
allowed us to identify the high affinity IgG receptor FcyRl (CD64) as critical 
for binding secreted IgG to the surface of the antigen capturing cells. IgG 
clearly has an important roles in regulating T-dependent B cell responses 
although the precise mechanisms remain unknown. Delivery of specific IgG 
with soluble antigen can dramatically enhance primary antibody responses 
and promote the development of recall responses [139]. This effect is thought 
to be largely independent of complement and experiments in knock out mice 
have indicated that it is Fc'yRl, and not FcyRIII, which is necessary [139]. Two 
mechanisms have been proposed to account for IgG mediated enhancement 
of B cell responses: (1) localisation of antigen to FDCs and (2) targeting of 
antigen for presentation to T cells. The former seems unlikely because FcR y 
chain knock out mice, which lack FcyRl, actually have enhanced antigen 
deposition on FDC [147]. Antigen targeted to FcyRl on DCs has been shown 
to lead to activation and efficient antigen presentation on MHC class I and 
MHC classil in vitro. However, FcyRl is expressed by many other cell types, 
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including macrophages and monocytes, and the in vivo relevance of this 
antigen-presentation pathway is not know. 
ACC lack distinctive lineage markers and cannot be allocated to any of the 
known myeloid cell subsets. They do however express low to intermediate 
levels of MHC classil, high levels of MHC class I and are CD40 - a phenotype 
that is suggestive of APC function. The relative rarity of ACC made in vitro 
functional assessment impractical at this time, although this would be 
desirable in the future. Therefore, to gain clues as to the potential roles of 
ACC in vivo, B and T cell secondary responses in FcR y  chain -/ mice were 
examined. This is an interesting issue in itself, which has been addressed in 
only studies that reached contradictory conclusions regarding the role of 
chain Fc receptors in the development of B cell responses [147], [148]. 
While no defect was detected in primary, long lived and secondary IgG 
responses to a TD antigen in intact FcR 7 -I- mice, there does seem to be a 
defect in helper T cell memory. It is not clear at this stage if this is a defect in 
the formation or maintenance of the CD4 memory T cell pool. Once this has 
been established, the next step in this project would be to transfer ACC from 
wild type mice to see if this subset can correct the defect. The role of B cells in 
generating and maintaining memory T cell responses has been studied for 
over a decade but is unresolved. These experiments, together with recent 
studies by others [148], [152], [199] highlight that it may be antibody rather 
than B cells per se that regulate CD4 T cells. 
137 
I have been unable to reach any firm conclusions regarding the requirement 
for CD40-CD154 signals in the development of non-switched B cell memory. 
Re-challenge experiments in CD40-/- mice showed that 1gM recall responses, 
as measured by antigen specific ELISA, are enhanced in both CD40+ and 
wild type mice. This supports the earlier findings of Gray and co-workers that 
recall 1gM responses where enhanced in mice treated with CD40-Ig [185]. The 
enhancement of secondary 1gM responses in CD40 -/- mice is due in part to the 
priming of helper T cells and partly to memory in the B cell compartment. 
However, the level of enhancement is very low. Using a VH RT-PCR based 
isotype specific technique another group has demonstrated the existence of a 
robust 1gM memory response in normal mice, and found upregulation of 
specific 1gM transcripts on recall to be equivalent to that seen for specific Ig 
Gi [123]. That study implied that the true extent of secondary 1gM responses 
is masked in affinity biased ELISA assays of serum 1gM. We decided to 
investigate 1gM responses in CD40-/- mice using the same CDR3/isotype 
specific VH RT-PCR method. The discovery that the hapten specific VH motif 
which normally dominates the wild type response, does not feature in the 
CD40-/- response, was unexpected. This meant the 1gM responses to the 
hapten in CD40/- and wild type mice could not be compared. A recent study 
has supported the existence of a CD40 independent pathway for memory B 
cell generation in humans [124]. It will be important to develop a mouse 
model for studying this phenomenon. One strategy, which has not yet been 
explored, would be to use BCR transgenic mice crossed on to a CD401 
background. This would allow all stages of memory B cell generation, i.e. 
recruitment, diversification, maintenance and reactivation to be studied in 
CD401 mice. 
Materials and Methods 
Animals 
All mice were maintained under specific pathogen free conditions. C57BL/6 
and BALB/c mice were either purchased from Harlan or bred in house. 
Syngneic B6 IgHa mice were purchased from Harlan. B6 RAG-I- mice were 
isolator reared and maintained. B6-CD40-I- mice [92] were bred and 
maintained in filter-top cages. BALB/c CD401 F3 mice were the gift of Dr 
John Forrester, University of Aberdeen. Clq-I- [159], C2/BF-I- [160], FcyRIII I 
[200] and FcR y chain -I- [166] mice were kindly provided by Dr Marina Botto, 
Imperial College Sch000l of Medecine, London. Quasi-monoclonal (QM) mice 
[155] were donated by Dr Peter Lane, University of Birmingham, with the 
permission of Dr Mattias Wabl, UCSF, San Francisco. 2mI mice were 
provided by Dr Rick Maizels, University of Edinburgh. Animals were aged 6-
10 weeks when immunised and were sex and aged matched as closely as 
possible. 
Antigens 
R-phycoerythrin (PE) and allophycocyanin (APC) both from Prozyme; 
Ovalbumin (OVA, Sigma); bovine serum albumin (BSA, Sigma); keyhole 
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limpet haemocyanin (KLH, calbiochem) were used as protein antigens. KLH, 
and BSA were coupled to dinitrophenyl (DNP) by reacting with 23j.tl of 
dinitrofluorobenzene (DNFB, Sigma) solution (in oil) in 0.1M sodium borate 
buffer, pH 8.4 (Sigma) per mg of protein. PE and BSA were coupled to 
nitrophenyl (NP) by reacting with 40p.g or 200pg, respectively, of NP-O-suc 
(Biosearch Technologies Inc.) in dimethyl formamide(DMF, Sigma), in 0.2M 
carbonate/ bicarbonate buffered to pH9. In each case hapten conjugates were 
dialysed against PBS to remove free hapten. Chicken serum albumin (CSA) 
and phenyloxazolone (PhOx) haptenated GSA (GSA-Ox) were provided by Dr 
Harry White, Institute of Child Health, London. Where required protein 
antigens were alum precipitated in 4.5% potassium alum (Sigma) solution 
and washed extensively in PBS 
Immunisations 
With fluorescent antigens primary immunisations were 50 or 100pg soluble 
PE or APC, intraperitoneally (ip), in 200pJ PBS plus 10 9 killled Bordetella 
pertussis (Calbiochem); boost doses were as primary challenge, either with or 
without pertussis. For CD40 -/ - memory experiments primary and secondary 
immunisation were with 100pg soluble KLH or DNP-KLH, ip. For PhOx 
specific Ig RT-PCR studies primary immunisations were with 100tg of alum 
precipitated GSA or GSA-Ox, plus 10 9 pertussis, ip; boost doses were with 
lOOp.g of soluble GSA-Ox, ip. 
Cell preparations 
140 
Single cells suspensions of spleen were prepared in 2% FCS HANKS buffer 
(Sigma), by pressing through nylon gauze (SST). Red blood cells were 
removed through hypotonic lysis by incubation in Gey's solution and 
washed. 100-200p.l of peripheral blood was collected from mice tails into 50tl 
heparin (CP Pharmaceuticals) and centrifuged over lympholyte-M 
(Cerdarlane Laboratories) to remove red blood cells. Bone marrow cells were 
flushed from both femurs using HANKS buffer. 
Intra-venous transfer of anti-PE serum 
C57BL/6 mice immunised with PE, around 8 weeks, earlier were boosted 
with 50i.g of PE and bled out under anaesthetic 7 days later. Blood was 
allowed to coagulate occur at room temperature then centrifuged twice, 15 
000 rpm and serum was collected. Recipient C57BL/6 or RAG-/- mice were 
injected intravenously (iv) with 200jtl of serum and then another 200jtl after 
24 hours and then killed 18 hours later. 
Flow cytometry analysis. 
To detect NP, PE or APC binding cells, up to 10 6 cells were stained in 100[d 
FACS buffer (PBS 1% NCS), with 2.5pg/ml NP-PE, 2.5pg/ml PE or lOjig/mi 
APC, 15 minutes on ice, then washed immediately in FACS buffer. MAbs: 
anti-B220/ RA3-6B2-FITC, PE, PerCP; anti-CD21 / 7G6-FITC; anti-CD138/ 281-
2-biotin; anti-CD43/ S7-biotin and anti-CD11c/ N418-FITC; anti-CD1 / 1B1-
biotin were purchased from Pharmingen. F480-FITC and anti-CD11b/M1/70-
FITC were purchased from Sigma. 331D and DEC-205 were provided by Dr 
Sarah Howie, University of Edinburgh. Polyclonal goat anti-mouse IgM-biotin 
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and IgG-FITC were purchased from Southern Biotech, Anti-CD45-FITC was 
the gift of Dr Victor Tubulevich, London. Anti-CD4/GK1.5-FITC, anti-
CD8/53.6.72-biotin, anti-MHC class II/M5114-biotin, anti-MHC 
classl/ Ml / 42-biotin, anti-Id(QM)/R2.248-biotin and anti-CD40/ FGK-45 were 
produced in house. Supernantants from tissue culture of hybridoma cell lines 
grown in 2% FCS IMDM (Sigma) were filtered to remove cells. 
Immunoglobulin was precipitated in 50% saturated ammonium sulphate 
(Sigma). Precipitates were dissolved in PBS and extensively dialysed against 
PBS. Antibodies were purified by binding to a protein G-sepharose column 
(Pharmacia) at pH 7 and elution at pH 2.8. Purified antibodies were 
conjugated to biotin by reacting with 75tg succinimidyl-6-(biotinamido) 
hexanoate (EZ-LinkTM NHS-LC-Biotin, Pierce) in DMF (Sigma) per 1mg of Ig; 
or antibodies were conjugated to FITC by reacting with SOng FITC per mg Ig 
in 0.15M sodium chlloride/50mM sodium carbonate, pH 9 buffer. In both 
cases conjugated antibodies were dialysed against PBS. Secondary reagents: 
streptavidin-PE (Calbiochem), streptavidin-FITC (Sigma), streptavidin-cy5 
(Amersham), mouse (Fab) anti-rat IgG-FITC (Jackson Laoratories). Cells were 
incubated with primary reagents in FACS buffer, 20 min on ice, then washed 
3 times and where required incubated with secondary reagents, 20 min on ice. 
Cells were resuspended in PBS for flow cytometry analysis on a FACScalibur 
(Becton Dickinson). Where necessary, dead cells were excluded by adding 7-
amino-actinomycin D (7AAD) to 1pg/ml (Sigma), 60 seconds before analysis. 
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Measurement of antigen and isotype specific serum Ig by EL ISA 
Blood collected from the tail veins of mice was allowed to coagulate at room 
temperature then centrifuged twice (15 000 rpm) and serum was collected. 96 
well PVC microtitre plates (Dynex Technologies Inc.), were coated with 
50g/m1 antigen in 0.1M carbonate/ bicarbonate buffer, pH 9.6, overnight at 
4°C. Plates were washed in PBS and blocked with PBS 1% BSA, for 2 hours at 
room temperature. Plates were washed and serum was added in two fold 
dilutions in PBS 1% BSA and incubated 4 h at room temperature or overnight, 
4°C. Plates were washed in PBS and incubated with alkaline phosphatase 
(AP) conjugated polyclonal goat, anti-mouse 1gM or IgG (Southern Biotech) in 
PBS 0.05% tween-20, 2 h at room temperature. Alternatively, for antiIgG1a 
detection plates were incubated with MAb 10.2-biotin (Pharmingen) for 2 
hours, followed by a 1 hour incubation with stretavidin-AP (Southern 
Biotech). In each case plates were developed with PNPP substrate buffer 
(Southern Biotech) and the optical density (OD) at 405 nm was measured. 
Antibody titres were calculated by plotting serum concentration against OD, 
and reading the dilution at the half-maximal OD, compared with a positive 
control. For anti-DNP 1gM, comparison with a mouse anti-DNP 1gM 
monoclonal standard (hybridoma made by Dr David Gray) was used to 
estimate the serum antibody concentration. 
BrdU labelling assay 
Mice were given 5-Bromo-2'-deoxyuridine (BrdU, Sigma), 0.8 mg/ml in their 
drinking water for 4 days, then killed. The BrdU drinking water was made 
fresh each day and protected from the light. Splenocytes and bone marrow 
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were harvested and single-cell suspensions made. 10 6 cells were stained with 
PE as for FACS, then washed in PBS and resuspended in 0.5m1 0.15M NaCl. 
Whilst gently vortexing 1.2m1 of ice-cold 95% ethanol was added, then cells 
were washed in PBS and resuspended in lml 1% paraformaldehyde 0.01% 
tween-20, 30min at room temperature. Cells were centrifuged and 
resuspended in DNAse I (Sigma) solution (50U/ml DNAse 14.2 mM 
MgC12/0.15 M NaCl, pH5), 10 min at room temperature, washed in PBS then 
resuspended in lOjil anti-BrdU-FITC (Becton Dickinson), 30 min room 
temperature. Cells were washed in PBS before being analysed by FAGS. 
EL/SPOT assay for antigen-specific /g secreting cells 
96 well nitrocellulose plates (Millipore) were coated with lOp.g/ml PE in 0.1M 
carbonate/ bicarbonate buffer, pH 9.6, overnight at 4°C. Plates were washed in 
PBS and blocked with PBS 10% FCS, for 2 hours at room temperature. 5 or 3 
fold dilutions of spleen or bone marrow cell suspensions, in complete IMDM, 
were added in quadruplicate, over the range 5 x 10 - 10 6 total white cells per 
well. Plates were incubated for 5-8 hours at 37°C, 5% CO2. Plates were washed 
thoroughly: thrice with PBS, thrice with PBS 0.05% tween-20, then thrice again 
with PBS. The secondary antibody, polyclonal goat, anti-mouse IgG-AP 
(Southern Biotech) was added in PBS 5% BSA, 4 hours at room temperature, 
then washed thoroughly as before. Spots were developed by incubation with 
1mg/mi 5-Bromo 4 chlorophosphate (BCIP, Sigma) in 0.1M Tris (Sigma) pH9 
plus 5mM MgCl (Sigma) plus 0.1M NaCl (Sigma). Spots were scored by eye 
using a dissection microscope and the average number of spots per well was 
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used to calculate the frequency of PE specific IgG secreting cells. Spleen and 
bone marrow from unimmunised control mice consistently gave no spots per 
106 cells. 
Macropinocytosis assay 
Single cell suspensions of splenocytes from FE immunised mice, or of bone 
marrow-derived mouse dendritic cells, were incubated in 10% FCS IMDM at 
2 x 107  cells per ml with 1mg/mi FITC-dextran (Mr=40 000, Molecular Probes) 
for 0, 4, 7, 15, 30 or 60 minutes; on ice or at 37°C. Immediately after incubation 
cells were washed 4x in ice cold PBS 1% FCS 0.02% NaN3. Cells were then 
stained for FACS with CD19 and PE or with anti-MHC class II. Dead cells 
were excluded using 7AAD. Method modified from Sallusto et al. [165]. DCs 
were grown from mouse bone marrow by culturing it with 5% recombinant 
GMCSF supernatant IMDM for 5 days, then non-adherent cells were cultured 
for a further day before use. 
LPS stimulation of QM bone marrow 
Bone marrow cells from QM mice were stimulated with or without lOp.g/ml 
LPS in 5% FCS IMDM for 24 and 48 hours, 37°C, 5% CO2. Cells were 
harvested and washed, then stained for FACS with anti-MHC class II, anti-
CD19 and NP-FE. 
Phenyl Oxazolone specific immuno globulin RT-PCR 
RT-PCR: 10% of whole spleen suspension was pelleted. Cell lysis and total 
RNA extraction was carried out using RNAzo1 B reagent (Biogenesis) 
according to manufacturers instructions. 10% of RNA extracted was 
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denatured at 96°C for 3 min with 0.5 tg of oligo-dT and placed on ice before 
being reverse transcribed in a 50-pd reaction for 1 h at 42°C (oligo-dT) with lx 
RT buffer, 0.2 mM dNTPs, 1 mM dithiothreitol, 800 U/mI RNAsin (Promega), 
and 400 U of MoMuLV reverse transcriptase (all from Life Technologies 
except where indicated). 
First round PCR (see Figure 24) was performed with 2 pd of cDNA reaction 
with standard reaction conditions using manufacturers?  supplied buffer with 
Pfu-turbo polymerase (Stratagene) and 20 pmol of both a VHOX-1 CDR2 
specific primer (OXC2: GGTGGAAGCACAAATTATAATTCG) and 
membrane 1gM (Mmem: TCTGGGGCTTTGCACTCTGAGAGG) or secretory 
1gM (Msec: GCCTTCCTCCTCAGCATTCACCTC) CM-specific primer, in a 
50-pJ reaction for 30 cycles with the following cycling: 96°C, 30 s; 59°C, 30 s; 
72°C, 2 mm; preceded by an incubation at 96°C for 3 min before addition of 
polymerase. 
For each single run-off reaction equivalent, 2 pmol of nested isotype-specific 
primer was end-labeled with 3 tCi of -[33P]dATP (2,500 Ci/mmol; 
Amersham Pharmacia Biotech) using the User Friendly T4 polynucleotide 
kinase labeling system (Amersham Pharmacia Biotech). The reaction was 
NaOAc/EtOH precipitated and washed with 75% EtOH before use. Run-off 
reactions were performed for 12 cycles in a 20-pd volume with Pfu-turbo 
polymerase and buffer as before using 2 p1 of the first-round PCR product 
with the following cycling: 96°C, 30 s; 60°C, 30 s; 72°C, 1 mm. After cycling, 
reactions were treated as for standard sequencing gel electrophoresis and run 
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on 5% acrylamide/urea gels, dried, and exposed to x-ray film (Kodak XAR 
and Biomax films 
CDR3 Sequence Determination. For PAGE purification of C6 transcripts, 
quadruple-sized run-off samples from the pooled PCR product of all three 
mice in a cohort were loaded on triple-width wells, electrophoresed, and 
located by autoradiography. Bands were cut out from the dried gel with fine 
scissors, soaked for 10 min in 100 tl of water, heated to 100°C for 15 mm, and 
centrifuged at 15,000 rpm for 2 mm. DNA was recovered from the 
supernatant by addition of 10 jig of linear polyacrylamide and NaOAc/EtOH 
precipitation on dry ice. After centrifugation, the pellet was washed with 75% 
EtOH, air dried, and redissolved in 10 jil of water. 4 jil of this was used in a 
50-pd, 15-cycle PCR with Taq polymerase and manufacturers' supplied buffer 
with conditions as above and the OXC2 and appropriate nested isotype-
specific primer that was also used in the run-off, with the following cycling: 
94°C, 30 5; 59°C, 30 s; 72°C, 1 mm. 2 jil of this product was TOPO-TA cloned, 
transformed into Escherichia coli TOP-b, and plated out on selective media 
according to manufacturer's instructions (Invitrogen). Individual colonies 
were picked and directly amplified for 25 cycles with Pfu-turbo (Stratagene), 
conditions as above, using the OXC2 and appropriate nested isotype-specific 
primer. 1 p.1 of this product was sequenced using the ABI Big-Dye kit 
(PerkinElmer) and analyzed on an ABI 377 DNA sequencer. 
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Assessment of helper T cell memory by adoptive transfer 
The mice to be tested for helper T cell memory, wild type C57BL/6 mice and 
FcR y  chain-/- mice were primed with 50 jig PE and pertussis 22 weeks later 
spleen were harvested and total splenocytes containing pre-determined 
numbers of CD4 T cells were transferred i.v. into host C57BL/6 mice that 
had been sub-lethally irradiated (500 Rads) 24 hours earlier. 5 x 10 6 total, RBC 
depleted, splenocytes from syngeneic 136-IgHa mice, primed 4 weeks earlier 
with NP-KLH, were co-transferred. 12 hours after transfer, all recipients were 
challenged i.p. with lOj.ig NP-PE. 6 days after challenge all mice were bled, 
serum collected and ELISA for anti-NP IgGla performed. 
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